Case number 2:17-cv-02613
Immunex Corporation v. Sanofi et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 3, 2021 | 404 | REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # 1 Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021) (0) |
| Aug 2, 2021 | 403 | ORDER GRANTING JOINT MOTION TO DISMISS by Judge Andre Birotte Jr.: The parties' joint motion to dismiss pursuant to Federal Rule of Civil Procedure 4l(a)(2) and (c) 402 is GRANTED. All of Immunex's claims as to Defendants in the action are hereby DISMISSED WITH PREJUDICE. All of Defendants' counterclaims in the action are hereby DISMISSED WITHOUT PREJUDICE. As the prevailing party, Defendants shall be entitled to their costs amounting to $39,811.80 to be paid to Defendants within 30 days of the Court's order of dismissal. Each party shall bear its own attorneys' fees. ( MD JS-6. Case Terminated ) (gk) (Entered: 08/03/2021) (2) |
| Jul 30, 2021 | 402 | Joint NOTICE OF MOTION AND MOTION to Dismiss Case filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting Motion to Dismiss) (Takahashi, Heather Emily) (Entered: 07/30/2021) (0) |
| Apr 8, 2021 | 401 | STATUS REPORT JOINT STATUS REPORT REGARDING PENDING APPEALS OF RELATED INTER PARTES REVIEW PROCEEDINGS filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 04/08/2021) (6) |
| Jan 12, 2021 | 400 | ORDER GRANTING JOINT MOTION TO CONTINUE THE PRETRIAL CONFERENCE AND TRIAL by Judge Andre Birotte Jr.: Upon the parties' Joint Motion 399 , the Court VACATES all remaining pretrial and trial dates and ORDERS the parties to submit status reports every 120 days beginning on 4/9/2021. The parties must also file a joint status report within seven days from the date on which all appeals from the related IPR proceedings are exhausted that includes a brief summary of the remaining issues and provides new proposed pretrial and trial dates. (gk) (Entered: 01/13/2021) (2) |
| Jan 11, 2021 | 399 | Joint NOTICE OF MOTION AND MOTION to Continue the Pretrial Conference and Trial from February 2021 to Year 2022 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order) (Garvish, John) (Entered: 01/11/2021) (0) |
| Nov 25, 2020 | 398 | NOTICE Immunex's Updated Notice Regarding Pending Appeals of Inter Partes Review Proceedings filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Takahashi, Heather Emily) (Entered: 11/25/2020) (5) |
| Oct 23, 2020 | 396 | NOTICE of Decision: Federal Circuit filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A)(Garvish, John) (Entered: 10/23/2020) (0) |
| Oct 23, 2020 | 397 | NOTICE Immunex's Notice Regarding Pending Appeals of Inter Partes Review Proceedings filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Takahashi, Heather Emily) (Entered: 10/23/2020) (4) |
| Oct 15, 2020 | 395 | Notice of Appearance or Withdrawal of Counsel: for attorney John F Garvish counsel for Counter Claimants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC, Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Roderick G. Dorman is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendants and Counterclaim-Plaintiffs Sanofi; Sanofi-Aventis U.S. LLC; Genzyme Corp.; Aventisub LLC; Regeneron Pharmaceuticals, Inc.. (Garvish, John) (Entered: 10/15/2020) (2) |
| Oct 7, 2020 | 394 | Notice of Appearance or Withdrawal of Counsel: for attorney Sami Sedghani counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Sami Sedghani is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counter-Defendants Immunex Corporation and Amgen Inc.. (Sedghani, Sami) (Entered: 10/07/2020) (3) |
| Sep 30, 2020 | 393 | STATUS REPORT JOINT STATUS REPORT REGARDING PENDING APPEALS OF RELATED INTER PARTES REVIEW PROCEEDINGS filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 09/30/2020) (6) |
| May 18, 2020 | 392 | Notice of Appearance or Withdrawal of Counsel: for attorney Heather Emily Fitzgerald Takahashi counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Katherine Nicole Clouse is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counterclaim-Defendants Immunex Corporation and Amgen Inc.. (Takahashi, Heather Emily) (Entered: 05/18/2020) (2) |
| May 15, 2020 | 391 | Notice of Appearance or Withdrawal of Counsel: for attorney Heather Emily Fitzgerald Takahashi counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Sarah G. Boyce is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counterclaim Defendants Immunex Corporation and Amgen Inc.. (Takahashi, Heather Emily) (Entered: 05/15/2020) (2) |
| Apr 27, 2020 | 390 | MINUTES (IN CHAMBERS) ORDER CONTINUING FINAL PRE-TRIAL CONFERENCE AND TRIAL DATES by Judge Andre Birotte Jr.: In light of the parties' Status Report 389 , the Court hereby continues the Final Pretrial Conference to 2/5/2021 11:00 AM before Judge Andre Birotte Jr. Jury Trial is continued to 2/23/2021 09:00 AM before Judge Andre Birotte Jr. Court Reporter: N/A. (gk) (Entered: 04/27/2020) (1) |
| Apr 20, 2020 | 389 | STATUS REPORT JOINT STATUS REPORT REGARDING PENDING APPEALS OF RELATED INTER PARTES REVIEW PROCEEDINGS filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 04/20/2020) (6) |
| Apr 7, 2020 | 387 | STANDING ORDER upon filing of the complaint by Judge Andre Birotte Jr. (cb) (Entered: 04/07/2020) (14) |
| Apr 7, 2020 | 388 | MINUTE ORDER In Chambers] ORDER CONTINUING FINAL PRETRIAL CONFERENCE DATE AND TRIAL DATE by Judge Andre Birotte Jr. The Court, on its own motion, hereby continues the final pretrial conference to August 28, 2020, at 11:00 a.m., and continues the trial date to September 22, 2020, at 8:30 a.m. (lom) (Entered: 04/07/2020) (1) |
| Apr 6, 2020 | 386 | ORDER TO REASSIGN CASE due to self-recusal pursuant to General Order 19-03 by Judge John A. Kronstadt. Case transferred from Judge John A. Kronstadt to the calendar of Judge Andre Birotte Jr for all further proceedings. Case number now reads as 2:17-cv-02613 AB(PLAx). (rn) (Entered: 04/06/2020) (1) |
| Apr 2, 2020 | 385 | ORDER OF THE CHIEF JUDGE (#20-052) approved by Judge Virginia A. Phillips. IT IS ORDERED, with the concurrence of the Case Management and Assignment Committee, that the following cases be reassigned from the calendar of Judge S. James Otero to the Calendar of Judge John A. Kronstadt for all futher proceedings. The case number will now reflect the initials of the transferee Judge 2:17-cv-02613 JAK(PLAx). (rn) (Entered: 04/03/2020) (1) |
| Mar 11, 2020 | 382 | Notice of Appearance or Withdrawal of Counsel: for attorney Heather Emily Fitzgerald Takahashi counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Carly Romanowicz is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 03/11/2020) (2) |
| Mar 11, 2020 | 383 | NOTICE of Change of address by Heather Emily Fitzgerald Takahashi attorney for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Changing attorneys address to Sarah Chapin Columbia, 200 Clarendon Street, Floor 58, Boston, MA 02116-5021. Filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 03/11/2020) (2) |
| Mar 11, 2020 | 384 | NOTICE of Change of address by Heather Emily Fitzgerald Takahashi attorney for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Changing attorneys address to Katherine Nicole Clouse, 200 Clarendon Street, Floor 58, Boston MA 02116-5021. Filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 03/11/2020) (2) |
| Oct 9, 2019 | 381 | SCHEDULING NOTICE by Judge S. James Otero. Having reviewed the parties' joint status report the court continues the Jury Trial set for 01/14/20 to Tuesday, 09/15/2020 @ 09:00 AM and the Pretrial Conference set for 12/16/19 to Monday, 8/17/2020 @ 09:00 AM before Judge S. James Otero. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 10/09/2019) (0) |
| Oct 7, 2019 | 380 | STATUS REPORT JOINT STATUS REPORT REGARDING PENDING APPEALS OF RELATED INTER PARTES REVIEW PROCEEDINGS filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 10/07/2019) (6) |
| Sep 18, 2019 | 379 | SCHEDULING NOTICE by Judge S. James Otero previously scheduled for 9/23/19 11/5/19 has been rescheduled. The Court continues the PTC from 9/23/19 to 12/16/19 @ 9 a.m. and the Jury Trial from 11/05/19 to 1/14/2020 @ 09:00 AM before Judge S. James Otero. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 09/18/2019) (0) |
| Jun 13, 2019 | 378 | Notice of Appearance or Withdrawal of Counsel: for attorney Elizabeth A Laughton counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Elizabeth A. Laughton is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counterclaim-Defendants Immunex Corporation and Amgen Inc. Elizabeth A. Laughton. (Laughton, Elizabeth) (Entered: 06/13/2019) (3) |
| Feb 27, 2019 | 377 | ORDER GRANTING JOINT STIPULATION TO STAY CASE PENDING APPEAL OF INTER PARTES REVIEW 376 by Judge S. James Otero. This matter is stayed pending any rehearings or appeals of the inter partes review proceedings in IPR2017-01879 and IPR2017-01884. The parties shall file a joint status report within seven days from the date on which all appeals of the PTABs decisions in IPR2017-01879 and IPR2017-01884 are exhausted or the time to appeal in both IPRs has expired. (lom) (Entered: 02/28/2019) (2) |
| Feb 20, 2019 | 376 | Joint STIPULATION to Stay Case pending Appeal Of Inter Partes Review filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting Joint Stipulation To Stay Case Pending Appeal Of Inter Partes Review)(Takahashi, Heather Emily) (Entered: 02/20/2019) (0) |
| Feb 19, 2019 | 375 | NOTICE filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. of the European Patent Office's Revocation of the European Counterpart to the Patent in Suit (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Garvish, John) (Entered: 02/19/2019) (0) |
| Feb 15, 2019 | 374 | NOTICE OF FINAL WRITTEN DECISIONS IN INTER PARTES REVIEW OF U.S. PATENT NO. 8,679,487 filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Exhibit A A_IPR2017-01879, # 2 Exhibit B B_IPR2017-01884)(Takahashi, Heather Emily) (Entered: 02/15/2019) (0) |
| Feb 11, 2019 | 373 | ORDER GRANTING JOINT APPLICATION TO EXTEND CLOSE OF FACT DISCOVERY FOR PURPOSE OF TAKING A FACT WITNESS DEPOSITION 372 by Judge S. James Otero : Dispositive Motion Cut-Off June 14, 2019 (Friday); Last Day for Hearing Motions July 22, 2019 (Monday) 10:00 a.m.; Pretrial Conference September 23, 2019 (Monday) 9:00 a.m. Jury Trial November 5, 2019 (Tuesday) 9:00 a.m. (SEE DOCUMENT FOR OTHER DEADLINES). (lc) (Entered: 02/11/2019) (2) |
| Feb 7, 2019 | 372 | Joint STIPULATION to Extend Close of Fact Discovery For Purpose of Taking A Fact Witness Deposition Order on Motion to Amend/Correct, 316 filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting Joint Application to Extend Close of Fact Discovery For Purpose of Taking A Fact Witness Deposition)(Takahashi, Heather Emily) (Entered: 02/07/2019) (0) |
| Dec 17, 2018 | 370 | ORDER GRANTING APPLICATION of Non-Resident Attorney Eric S. Hansen to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC and designating Roderick G Dorman as local counsel 362 by Judge S. James Otero (lc) (Entered: 12/17/2018) (1) |
| Dec 17, 2018 | 371 | ORDER GRANTING JOINT APPLICATION TO EXTEND REMAINING CASE DEADLINES 369 by Judge S. James Otero:, The deadlines and hearings originally scheduled have been rescheduled: Discovery cut-off 2/8/2019; Motions due by 6/14/2019; Last day foR settlement conference : 45 days prior to hearing on dispostive motions; Pretrial Conference set for 9/23/2019 09:00 AM; Jury Trial set for 11/5/2019 09:00 AM. (SEE DOCUMENT FOR OTHER SPECIFIC DEADLINES). (lc) (Entered: 12/17/2018) (4) |
| Dec 13, 2018 | 368 | SEALED DOCUMENT Joint Stipulation regarding Defendants' Motion to Compel and Selected Exhibits re Order on Motion for Leave to File Document Under Seal 367 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit 3 to Takahashi Decl. In Opposition to Defendants' Motion to Compel, # 2 Exhibit 4 to Takahashi Decl. In Opposition to Defendants' Motion to Compel, # 3 Exhibit 3 to Lelutiu Declaration In Support of Defendants' Motion to Compel, # 4 Exhibit 4 to Lelutiu Declaration In Support of Defendants' Motion to Compel)(Takahashi, Heather Emily) (Entered: 12/13/2018) (0) |
| Dec 13, 2018 | 369 | Joint STIPULATION to Amend Order on Motion to Amend/Correct, 316 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 12/13/2018) (0) |
| Dec 7, 2018 | 367 | ORDER GRANTING IMMUNEX AND AMGEN'S APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Magistrate Judge Paul L. Abrams: granting 365 APPLICATION to Seal Document. Re: 366 . (sbou) (Entered: 12/10/2018) (2) |
| Dec 4, 2018 | 365 | APPLICATION to file document Documents Related to Defendants' Motion to Compel under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 12/04/2018) (0) |
| Dec 4, 2018 | 366 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Documents Related to Defendants' Motion to Compel under seal 365 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.(Takahashi, Heather Emily) (Entered: 12/04/2018) (0) |
| Nov 27, 2018 | 364 | ORDER GRANTING DEFENDANTS' APPLICATION FOR LEAVE TO FILE UNDER SEAL JOINT STIPULATION REGARDING DEFENDANTS' MOTION TO COMPEL; EXHIBITS 3 AND 4 TO DECLARATION OF RADU A. LELUTIU; AND EXHIBITS 3 AND 4 TO DECLARATION OF HEATHER E. TAKAHASHI by Magistrate Judge Paul L. Abrams:granting 356 APPLICATION to Seal Document. Re: Sealed Declaration in, 351 . (sbou) (Entered: 11/28/2018) (2) |
| Nov 26, 2018 | 362 | APPLICATION of Non-Resident Attorney Eric S. Hansen to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-22792129) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Good Standing, # 2 Proposed Order) (Garvish, John) (Entered: 11/26/2018) (0) |
| Nov 26, 2018 | 363 | ORDER RE: DEFENDANTS' MOTION TO COMPEL by Magistrate Judge Paul L. Abrams. Defendants' Motion is GRANTED IN PART and DENIED IN PART, as set forth above.NO LATER THAN DECEMBER 7, 2018, Immunex shall produce a declaration, or alternatively a further response to Interrogatory number 30, in accordance with this Order. It is so ordered. SEE ORDER FOR DETAILS. 355 (ch) (Entered: 11/26/2018) (14) |
| Nov 21, 2018 | 361 | SCHEDULING NOTICE TEXT ONLY ENTRY (In Chambers) by Magistrate Judge Paul L. Abrams. The Court has reviewed defendants' Motion to Compel (ECF No. 355) as well as the various documents submitted in connection with the Motion. The Court has concluded that oral argument will not be of material assistance in determining the Motion. The hearing scheduled for November 28, 2018, at 10:00 a.m. is vacated. The motion is taken under submission. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ch) TEXT ONLY ENTRY (Entered: 11/21/2018) (0) |
| Nov 16, 2018 | 360 | ORDER GRANTING APPLICATION of Non-Resident Attorney John B. Campbell to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC and designating Christine M Woodin as local counsel 353 , 358 by Judge S. James Otero (lc) Modified on 1/11/2019 (lc). (Entered: 11/16/2018) (1) |
| Nov 14, 2018 | 359 | SUPPLEMENT to MOTION to Compel Answers to Interrogatories of Immunex MOTION to Produce Responsive Documents 355 Supplemental Memorandum filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 11/14/2018) (8) |
| Nov 8, 2018 | 358 | Corrected APPLICATION of Non-Resident Attorney John B. Campbell to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - $400 Previously Paid on 11/5/2018, Receipt No. 0973-22694548) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Good Standing, # 2 Proposed Order) (Campbell, John) (Entered: 11/08/2018) (0) |
| Nov 7, 2018 | 355 | NOTICE OF MOTION AND MOTION to Compel Answers to Interrogatories of Immunex , MOTION to Produce Responsive Documents filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 11/28/2018 at 10:00 AM before Magistrate Judge Paul L. Abrams. (Attachments: # 1 Declaration of Radu A. Lelutiu, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Declaration Heather E. Takahashi, # 5 Exhibit 1, # 6 Exhibit 2, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Proposed Order)(Garvish, John) (Entered: 11/07/2018) (0) |
| Nov 7, 2018 | 356 | APPLICATION to file document Joint Stipulation Regarding Defendants' Motion to Compel under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 11/07/2018) (0) |
| Nov 7, 2018 | 357 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Joint Stipulation Regarding Defendants' Motion to Compel under seal 356 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Joint Stipulation Regarding Defendants' Motion to Compel, # 2 Unredacted Document Exhibit 3 to Lelutiu Decl., # 3 Unredacted Document Exhibit 4 to Lelutiu Decl., # 4 Unredacted Document Exhibit 3 to Takahashi Decl., # 5 Unredacted Document Exhibit 4 to Takahashi Decl.)(Garvish, John) (Entered: 11/07/2018) (0) |
| Nov 5, 2018 | 353 | APPLICATION of Non-Resident Attorney John B. Campbell to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-22694548) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Good Standing, # 2 Proposed Order) (Attorney John Bruce Campbell, Jr added to party Aventisub LLC(pty:dft), Attorney John Bruce Campbell, Jr added to party Genzyme Corporation(pty:dft), Attorney John Bruce Campbell, Jr added to party Regeneron Pharmaceuticals, Inc.(pty:dft), Attorney John Bruce Campbell, Jr added to party Sanofi(pty:dft), Attorney John Bruce Campbell, Jr added to party Sanofi-Aventis U.S. LLC(pty:dft)) (Campbell, John) (Entered: 11/05/2018) (0) |
| Nov 5, 2018 | 354 | NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney John B. Campbell to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - $400 Fee Paid, Receipt N 353 . The following error(s) was/were found: Local Rule 83-2.1.3.3(a) Application not complete: state and/or federal courts to which the applicant has been admitted are not listed. Local Rule 83-2.1.3.4 Local counsel does not maintain an office within the District. Other error(s) with document(s): State Bar and CM have attorney in Texas and application lists LA address. (lt) (Entered: 11/06/2018) (1) |
| Oct 31, 2018 | 352 | NOTICE of Appearance filed by attorney Elizabeth A Laughton on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Attorney Elizabeth A Laughton added to party Amgen Inc.(pty:cd), Attorney Elizabeth A Laughton added to party Immunex Corporation(pty:pla), Attorney Elizabeth A Laughton added to party Immunex Corporation(pty:cd))(Laughton, Elizabeth) (Entered: 10/31/2018) (2) |
| Oct 29, 2018 | 349 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE UNDER SEAL DEFENDANTS SECOND AMENDED ANSWER TO IMMUNEXS COMPLAINT FOR PATENT INFRINGEMENT AND COUNTERCLAIM-PLAINTIFFS SECOND AMENDED COUNTERCLAIMS AGAINSTIMMUNEX AND AMGEN 344 by Judge S. James Otero (lc) (Entered: 10/29/2018) (3) |
| Oct 29, 2018 | 350 | APPLICATION to file document Declaration of Heather E. Takahashi In Support of Immunex's Application for Leave to File Document Under Seal under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Application for Leave to File Document Under Seal)(Takahashi, Heather Emily) (Entered: 10/29/2018) (0) |
| Oct 29, 2018 | 351 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Declaration of Heather E. Takahashi In Support of Immunex's Application for Leave to File Document Under Seal under seal 350 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit 1 - Answer to Second Amended Counterclaims)(Takahashi, Heather Emily) (Entered: 10/29/2018) (0) |
| Oct 23, 2018 | 348 | ORDER GRANTING JOINT STIPULATION TO EXTEND MOTION TO COMPEL DEADLINE 347 by Judge S. James Otero: The deadline to file motions to compel to resolve any discovery disputes relating to depositions scheduled after October 23, 2018 and matters arising therefrom shall be extended to 14 days after the date of the last fact witness's deposition.Any discovery resulting from such motions to compel may be used to the same extent as discovery obtained on or before the December 14, 2018 close of fact discovery. (lc) Modified on 10/23/2018 (lc). (Entered: 10/23/2018) (2) |
| Oct 17, 2018 | 346 | NOTICE of Appearance filed by attorney Sami Sedghani on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Attorney Sami Sedghani added to party Amgen Inc.(pty:cd), Attorney Sami Sedghani added to party Immunex Corporation(pty:pla), Attorney Sami Sedghani added to party Immunex Corporation(pty:cd))(Sedghani, Sami) (Entered: 10/17/2018) (2) |
| Oct 17, 2018 | 347 | Joint STIPULATION for Extension of Time to File Motions to Compel filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 10/17/2018) (0) |
| Oct 15, 2018 | 344 | APPLICATION to file document Second Amended Answer under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 10/15/2018) (0) |
| Oct 15, 2018 | 345 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Second Amended Answer under seal 344 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Second Amended Answer)(Garvish, John) (Entered: 10/15/2018) (0) |
| Oct 12, 2018 | 343 | Notice of Appearance or Withdrawal of Counsel: for attorney John F Garvish counsel for Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Phillip J. Lee is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendants Sanofi; Sanofi-Aventis U.S. LLC; Genzyme Corp.; Aventisub LLC and Regeneron Pharmaceuticals, LLC. (Garvish, John) (Entered: 10/12/2018) (2) |
| Oct 4, 2018 | 341 | ORDER GRANTING JOINT STIPULATION TO ALLOW DEFENDANTS TO FILE SECOND AMENDED ANSWER by Judge S. James Otero. The undersigned hereby certifies that a true and correct copy of the above and foregoing document has been served on October 3, 2018, to all counsel of record who are deemed to have consented to electronic service via the Courts CM/ECF system. Any other counsel of record will be served by electronic mail, facsimile, U.S. Mail and/or overnight delivery. 340 (yl) (Entered: 10/10/2018) (3) |
| Oct 4, 2018 | 342 | ORDER GRANTING JOINT STIPULATION FOR DEFENDANTS TO AMEND INVALIDITY CONTENTIONS by Judge S. James Otero. Pursuant to the stipulation of the parties, and good cause appearing therefore, it is hereby ordered that Defendants shall be granted leave to serve their amended, Final Invalidity Contentions. IT IS SO ORDERED. 339 (yl) (Entered: 10/10/2018) (2) |
| Oct 3, 2018 | 339 | Joint STIPULATION to Amend Invalidity Contentions filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 10/03/2018) (0) |
| Oct 3, 2018 | 340 | Joint STIPULATION to File Second Amended Answer filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 10/03/2018) (0) |
| Sep 27, 2018 | 338 | MINUTES (IN CHAMBERS) by Judge S. James Otero:Having reviewed Docket Entries 110 , 135 , and 145 , the Court grants each of the individual Applications To Seal. (lc) (Entered: 09/27/2018) (1) |
| Aug 30, 2018 | 336 | ORDER GRANTING STIPULATION TO EXTEND DEADLIINE TO INVOKE ADVICE OF COUNSEL DEFENSE 335 by Judge S. James Otero : 1. The Deadline to Invoke Advice-of-Counsel Defense is extended until October 5, 2018; and 2. Should Defendants invoke the advice-of-counsel defense, the deadline for production under Northern District of California Patent Local Rule 3-7 is extended until October 5, 2018. (lc) (Entered: 08/31/2018) (3) |
| Aug 30, 2018 | 337 | MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER DENYING PLAINTIFF'S MOTION TO STAY 329 .This matter is before the Court on Plaintiff's Renewed Motion to Stay Case pending Inter Partes Review ("Motion"), filed August 13, 2018. Defendant opposed the Motion ("Opposition") on August 17, 2018, and Plaintiff replied ("Reply") on August 20, 2018. The Court found these matters suitable for disposition without oral argument. See Fed. R. Civ. P. 78(b). For thefollowing reasons, the Court DENIES Plaintiff's Motion. (lc) (Entered: 08/31/2018) (5) |
| Aug 27, 2018 | 335 | Joint STIPULATION for Extension of Time to File Extend Deadline to Invoke Advice-of-Counsel Defense filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 08/27/2018) (0) |
| Aug 24, 2018 | 334 | MINUTE ORDER IN CHAMBERS by Judge S. James Otero:CLAIM CONSTRUCTION ORDER; ORDER DENYING DEFENDANTS' MOTION FOR SUMMARY JUDGMENT 192 . (SEE DOCUMENT FOR SPECIFICS). (lc) (Entered: 08/27/2018) (21) |
| Aug 21, 2018 | 332 | RESPONSE filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporationto Text Only Scheduling Notice,, 327 Joint Response to Order at Docket No. 327 (Takahashi, Heather Emily) (Entered: 08/21/2018) (3) |
| Aug 20, 2018 | 331 | REPLY In Support of Renewed NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review 329 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Heather E. Takahashi in Support of Immunex's Reply In Support of Renewed Motino for Stay)(Takahashi, Heather Emily) (Entered: 08/20/2018) (0) |
| Aug 17, 2018 | 330 | OPPOSITION to Renewed NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review 329 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of Lauren L. Fornarotto)(Garvish, John) (Entered: 08/17/2018) (0) |
| Aug 15, 2018 | 333 | ORDER GRANTING JOINT STIPULATION TO EXPEDITE BRIEFING ON IMMUNEXS RENEWED MOTION TO STAY PENDING INTER PARTES REVIEW by Judge S. James Otero. Immunex will file its Renewed Motion to Stay Pending Inter Partes Review on Monday, August 13, 2018; Defendants will file their Opposition to the Renewed Motion to Stay Pending Inter Partes Review on Friday, August 17, 2018; and Immunex will file any Reply in support of its Renewed Motion to Stay Pending Inter Partes Review on Tuesday, August 21, 2018. (yl) (Entered: 08/24/2018) (3) |
| Aug 13, 2018 | 328 | Joint STIPULATION to Expedite Briefing on Immunex's Renewed Motion to Stay Pending Inter Partes Review filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting Joint Stipulation to Expedite Briefing)(Takahashi, Heather Emily) (Entered: 08/13/2018) (0) |
| Aug 13, 2018 | 329 | Renewed NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 9/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order Granting Immunex's Renewed Motion to Stay Pending Inter Partes Review) (Takahashi, Heather Emily) (Entered: 08/13/2018) (0) |
| Aug 8, 2018 | 327 | TEXT ONLY ENTRY by Judge S. James Otero re: Order on Motion for Summary Judgment 326 . Because the record in this case contains extensive material marked as confidential, the Court has issued its opinion dated August 7, 2018 under seal. The parties are hereby ordered to submit, in the form of a single joint response coordinated between the parties, a copy of the Court's order indicating which words, if any, are proposed to be redacted from the unsealed version of the opinion. This joint response shall be filed no later than 8/21/2018 and must be accompanied by a declaration specifically stating the cause for each requested redaction. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 08/08/2018) (0) |
| Aug 7, 2018 | 326 | SEALED MINUTES (IN CHAMBERS) CLAIM CONSTRUCTION ORDER; ORDER DENYING DEFENDANTS' MOTION FOR SUMMARY JUDGMENT 192 by Judge S. James Otero. The Court DENIES Defendants' Motion for Summary Judgment, and construes the disputed claim terms as follows: See document for details. (smo) (Entered: 08/08/2018) (0) |
| Aug 3, 2018 | 325 | Notice of Appearance or Withdrawal of Counsel: for attorney Heather Emily Fitzgerald Takahashi counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Wan-Shon Lo is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counterclaim-Defendants Immunex Corporation and Amgen Inc.. (Takahashi, Heather Emily) (Entered: 08/03/2018) (2) |
| Jul 27, 2018 | 323 | TRANSCRIPT for proceedings held on 7/12/18 10:01 a.m. Court Reporter: Carol Jean Zurborg, phone number (213) 894-3539. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 8/17/2018. Redacted Transcript Deadline set for 8/27/2018. Release of Transcript Restriction set for 10/25/2018. (Zurborg, Carol) (Entered: 07/27/2018) (82) |
| Jul 27, 2018 | 324 | NOTICE OF FILING TRANSCRIPT filed for proceedings 7/12/18 10:01 a.m. re Transcript 323 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Zurborg, Carol) TEXT ONLY ENTRY (Entered: 07/27/2018) (0) |
| Jul 16, 2018 | 322 | TRANSCRIPT ORDER as to Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC for Court Reporter. Court will contact Vicki Merideth at vmerideth@mckoolsmith.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the court reporter. (Garvish, John) (Entered: 07/16/2018) (2) |
| Jul 13, 2018 | 321 | TRANSCRIPT ORDER as to Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation for Court Reporter. Court will contact Myrna Perez at myrna.perez@mto.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the court reporter. (Takahashi, Heather Emily) (Entered: 07/13/2018) (2) |
| Jul 12, 2018 | 320 | MINUTES OF Claim Construction Hearing held before Judge S. James Otero: The Court takes this matter under submission. The Court Orders that a transcript of this proceeding shall be produced. Costs of transcripts to be shared by the parties. Court Reporter: Carol Zurborg. (lc) (Entered: 07/12/2018) (1) |
| Jul 6, 2018 | 318 | SEALED DOCUMENT Immunex's Supplemental Brief In Support of Claim Construction And In Opposition to Defendants' Motion for Summary Judgment re Order on Motion for Leave to File Document Under Seal, 314 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.(Takahashi, Heather Emily) (Entered: 07/06/2018) (0) |
| Jul 6, 2018 | 319 | SUPPLEMENT Brief In Support of Claim Construction And In Opposition To Defendants' Motion For Summary Judgment filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 07/06/2018) (16) |
| Jul 5, 2018 | 317 | SUPPLEMENT Defendants' Supplemental Brief in Support of Their Motion for Summary Judgment (Redacted Version) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 07/05/2018) (19) |
| Jun 25, 2018 | 316 | ORDER GRANTING JOINT APPLICATION TO EXTEND REMAINING CASE DEADLINES 315 by Judge S. James Otero: Close of Fact Discovery: 12/14/18; Dispositive motion cutoff: 4/26/19; Last day for hearing motions: 6/3/19 10:00AM; Pretrial Conference: 7/8/19 9:00 AM; Jury Trial 7/23/19 9:00 AM (SEE DOCUMENT FOR OTHER SPECIFIC DEADLINES) (lc) (Entered: 06/25/2018) (4) |
| Jun 22, 2018 | 315 | Joint APPLICATION to Amend Scheduling Conference - optional html form,,,, Vacate ADR Referral Notice,,,, Set/Reset Deadlines/Hearings,,, 80 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order) (Garvish, John) (Entered: 06/22/2018) (0) |
| Jun 21, 2018 | 314 | ORDER GRANTING DEFENDANTS' APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Judge S. James Otero: granting 312 APPLICATION to Seal Document. Immunex's Supplemental Brief In Support of Claim Construction and in Opposition to Defendants' Motion for Summary Judgment, and Exhibits K and L to the Declaration of S. Lo in Support of Immunex's Supplemental Brief shall be filed under seal in their entirety. (lom) (Entered: 06/21/2018) (2) |
| Jun 19, 2018 | 312 | APPLICATION to file document Immunex's Supplemental Brief and Exhibits K and L to the Lo Declaration under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Proposed Order)(Garvish, John) (Entered: 06/19/2018) (0) |
| Jun 19, 2018 | 313 | SEALED DOCUMENT Defendants' Supplemental Brief in Support of Their Motion for Summary Judgment re Order on Motion for Leave to File Document Under Seal 309 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC.(Garvish, John) (Entered: 06/19/2018) (0) |
| Jun 14, 2018 | 310 | SCHEDULING NOTICE RE CONTINUANCE OF CLAIM CONSTRUCTION HEARING by Judge S. James Otero. The Claim Construction hearing is continued from June 22, 2018 to July 12, 2018 at 10:00 a.m. The parties are ordered to appear at this new date and time. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (pso) TEXT ONLY ENTRY (Entered: 06/14/2018) (0) |
| Jun 14, 2018 | 311 | AMENDED SCHEDULING NOTICE RE CONTINUANCE OF CLAIM CONSTRUCTION HEARING/MOTION FOR SUMMARY JUDGMENT by Judge S. James Otero. The Motion for Summary Judgment/Claim Construction Hearing is continued from June 22, 2018 to July 12, 2018 at 10:00 a.m. The parties are ordered to appear at this new date and time. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (pso) TEXT ONLY ENTRY (Entered: 06/14/2018) (0) |
| Jun 8, 2018 | 309 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENT UNDER SEAL 307 by Judge S. James Otero (lc) (Entered: 06/08/2018) (2) |
| Jun 6, 2018 | 307 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Application for Leave to File Document Under Seal)(Takahashi, Heather Emily) (Entered: 06/06/2018) (0) |
| Jun 6, 2018 | 308 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 307 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.(Takahashi, Heather Emily) (Entered: 06/06/2018) (0) |
| Jun 1, 2018 | 304 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Amgen Inc., Immunex CorporationSupplement(Motion related), 303 . The following error(s) was/were found: The "supplemental brief" is only a Title page referencing the Unredacted version conditionally filed under seal. Filer should have filed a full Redacted version to which all the attached exhibits are in support thereof. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 06/01/2018) (1) |
| Jun 1, 2018 | 305 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 299 by Judge S. James Otero (lc) (Entered: 06/01/2018) (2) |
| Jun 1, 2018 | 306 | ORDER GRANTING DEFENDANTS Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. APPLICATION TO FILE DOCUMENTS UNDER SEAL 300 by Judge S. James Otero (lc) (Entered: 06/01/2018) (2) |
| May 31, 2018 | 299 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order)(Takahashi, Heather Emily) (Entered: 05/31/2018) (0) |
| May 31, 2018 | 300 | APPLICATION to file document Supplemental Brief under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 05/31/2018) (0) |
| May 31, 2018 | 301 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Supplemental Brief under seal 300 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Supplemental Brief in Support of Motion for Summary Judgment)(Garvish, John) (Entered: 05/31/2018) (0) |
| May 31, 2018 | 302 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 299 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Immunex's Supplemental Brief, # 2 Exhibit K to Lo Declaration, # 3 Exhibit L to Lo Declaration)(Takahashi, Heather Emily) (Entered: 05/31/2018) (0) |
| May 31, 2018 | 303 | SUPPLEMENT to NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 in Support of Claim Construction and in Opposition to Summary Judgment filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Wan-Sho Lo ISO Immunex's Supplemental Brief, # 2 Exhibit I to Lo Decl., # 3 Exhibit J to Lo Decl., # 4 Exhibit K to Lo Decl., # 5 Exhibit L to Lo Decl.)(Takahashi, Heather Emily) (Entered: 05/31/2018) (0) |
| May 8, 2018 | 298 | MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER DENYING DEFENDANTS' MOTION TO EXCLUDE UNTIMELY OPINIONS OF IMMUNEX'S EXPERTS 227 ; GRANTING IN PART ANDDENYING IN PART PLAINTIFF'S MOTION TO STRIKE PORTIONS OF ROBINSON DECLARATION 236 ; DENYING PLAINTIFF'S MOTION TO STAY 254 .The parties are ORDERED to filea supplemental brief of not more than 10) pages addressing the impact of this Order on the parties' respective positions on or before May 31, 2018. A hearing on the parties' Joint MSJ/Claim Construction briefs shall be SET for Friday, June 22, 2018 10:00 a.m. (lc) (Entered: 05/08/2018) (11) |
| May 4, 2018 | 295 | SEALED DOCUMENT Reply in Support of Defendants' Claim Construction Brief and Motion for Summary Judgment re Order on Motion for Leave to File Document Under Seal 279 , Order on Motion for Leave to File Document Under Seal 272 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Reply Statement of Undisputed Facts)(Garvish, John) (Entered: 05/04/2018) (0) |
| May 4, 2018 | 296 | OPPOSITION to NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review 254 (Public Version) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 05/04/2018) (12) |
| May 4, 2018 | 297 | SEALED DOCUMENT Declaration of Radu A. Lelutiu ISO Defendants' Opposition to Motion to Stay re Response in Opposition to Motion, 296 , Order on Motion for Leave to File Document Under Seal 293 , Order on Motion for Leave to File Document Under Seal 280 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Exhibit A, # 2 Unredacted Document Exhibit B)(Garvish, John) (Entered: 05/04/2018) (0) |
| Apr 23, 2018 | 294 | MINUTE ORDER IN CHAMBERS by Judge S. James Otero:Pending resolution of the three motions currently before the Court [ECF Nos. 227, 236, 254], the Court VACATES the claim construction and summary judgment hearing currently set for Friday, April 27, 2018. (lc) (Entered: 04/23/2018) (1) |
| Apr 19, 2018 | 293 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 291 by Judge S. James Otero (lc) (Entered: 04/19/2018) (2) |
| Apr 18, 2018 | 292 | OPPOSITION to NOTICE OF MOTION AND MOTION to Strike Portions of Robinson Declaration 236 (Redacted Version) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 04/18/2018) (27) |
| Apr 17, 2018 | 290 | SCHEDULING NOTICE by Judge S. James Otero re: Order on Motion to Expedite, 234 . The Motion for Summary Judgment/Markman Hearing shall be set for Friday, April 27, 2018 @ 10:00 a.m. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 04/17/2018) (0) |
| Apr 17, 2018 | 291 | APPLICATION to file document re Defendants' Exhibit 4 for Opposition to Motion to Strike and Exhbit B for Opposition to Motion to Stay under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Vincent Y. Ling ISO Application for Leave to File Documents Under Seal, # 2 Proposed Order Granting Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 04/17/2018) (0) |
| Apr 13, 2018 | 288 | SEALED DOCUMENT Defendants' Memorandum of Points and Authorities in Support of re NOTICE OF MOTION AND MOTION to Exclude Untimely Opinions of Immunex's Experts 227 , Order on Motion for Leave to File Document Under Seal,, 232 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Exhibit 2, # 2 Unredacted Document Exhibit 6)(Garvish, John) (Entered: 04/13/2018) (0) |
| Apr 13, 2018 | 289 | SEALED DOCUMENT Opposition to Immunex's Motion to Strike Portions of Robinson Declaration re Response in Opposition to Motion, 259 , Order on Motion for Leave to File Document Under Seal,, 261 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Declaration of William H. Robinson, Ph.D., M.D., # 2 Unredacted Document Exhibit 3, # 3 Unredacted Document Exhibit 5)(Garvish, John) (Entered: 04/13/2018) (0) |
| Apr 11, 2018 | 287 | The Court finds the following motion suitable for disposition without oral argument and vacates the MOTION to Stay Case pending Inter Partes Review filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. [ECF #254], set for hearing on April 16, 2018. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 04/11/2018) (0) |
| Apr 10, 2018 | 286 | SEALED DOCUMENT Immunex's Surreply and Supporting Documents re Order on Motion for Leave to File Document Under Seal 285 , NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit F to Lo Declaration, # 2 Exhibit H to Lo Declaration)(Takahashi, Heather Emily) (Entered: 04/10/2018) (0) |
| Apr 9, 2018 | 285 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 283 by Judge S. James Otero (lc) (Entered: 04/09/2018) (2) |
| Apr 6, 2018 | 281 | SEALED REPLY RE NOTICE OF MOTION AND MOTION to Strike Portions of Robinson Declaration 236 , Order on Motion for Leave to File Document Under Seal 269 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Michael J. Taussig ISO Immunex's Reply)(Takahashi, Heather Emily) (Entered: 04/06/2018) (0) |
| Apr 6, 2018 | 282 | Immunex's Surreply ISO Claim Construction and in Opposition to Defendants' Motion for Summary Judgment re NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Wan-Shon Lo ISO Immunex's Surreply ISO Claim Constructions and in Opposition to Defendants' MSJ, # 2 Exhibit F to Lo Decl. (Proposed to be Sealed), # 3 Exhibit G to Lo Decl., # 4 Exhibit H to Lo Decl. (Proposed to be Sealed))(Takahashi, Heather Emily) (Entered: 04/06/2018) (0) |
| Apr 6, 2018 | 283 | APPLICATION to file document related to Immunex's Surreply under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 04/06/2018) (0) |
| Apr 6, 2018 | 284 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document related to Immunex's Surreply under seal 283 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Surreply Statement of Genuine Disputes of Material Fact and Reply Statement of Undisputed Material Facts in Opposition to Defendants' Motion for Summary Judgment, # 2 Exhibit F to Lo Declaration, # 3 Exhibit H to Lo Declaration)(Takahashi, Heather Emily) (Entered: 04/06/2018) (0) |
| Apr 2, 2018 | 279 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 275 by Judge S. James Otero (lc) (Entered: 04/04/2018) (2) |
| Apr 2, 2018 | 280 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 273 by Judge S. James Otero (lc) (Entered: 04/04/2018) (2) |
| Mar 30, 2018 | 278 | REPLY In Support NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review 254 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 03/30/2018) (11) |
| Mar 27, 2018 | 276 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Amgen Inc., Immunex Corporation APPLICATION to file document Defendants' Markman and Summary Judgement Reply Documents under seal 275 . The following error(s) was/were found: No UN REDACTED documents submitted. For Assistance refer to the Court website regarding Guide to E-filing sealed documents.In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 03/27/2018) (2) |
| Mar 27, 2018 | 277 | The Court finds the following motion suitable for disposition without oral argument and vacates the MOTION to Strike Portions of Robinson Declaration filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. [ECF #236], set for hearing on April 2, 2018. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 03/27/2018) (0) |
| Mar 26, 2018 | 272 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 270 by Judge S. James Otero (lc) (Entered: 03/26/2018) (2) |
| Mar 26, 2018 | 273 | APPLICATION to file document Opposition to Immunex's Motion to Stay under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Proposed Order)(Garvish, John) (Entered: 03/26/2018) (0) |
| Mar 26, 2018 | 274 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Opposition to Immunex's Motion to Stay under seal 273 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Opposition to Immunex's Motion to Stay, # 2 Unredacted Document Declaration of Radu A. Lelutiu, # 3 Unredacted Document Exhibit A, # 4 Unredacted Document Exhibit B)(Garvish, John) (Entered: 03/26/2018) (0) |
| Mar 26, 2018 | 275 | APPLICATION to file document Defendants' Markman and Summary Judgement Reply Documents under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Vincent Y. Ling ISO Application for Leave to File Documents Under Seal, # 2 Proposed Order Granting Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 03/26/2018) (0) |
| Mar 23, 2018 | 270 | APPLICATION to file document Reply in Support of Defendants' Claim Construction Brief and Motion for Summary Judgment under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 03/23/2018) (0) |
| Mar 23, 2018 | 271 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Reply in Support of Defendants' Claim Construction Brief and Motion for Summary Judgment under seal 270 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Reply Statement of Undisputed Facts, # 2 Unredacted Document Reply in Support of Claim Construction Brief and Motion for Summary Judgment)(Garvish, John) (Entered: 03/23/2018) (0) |
| Mar 20, 2018 | 269 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 267 by Judge S. James Otero (lc) (Entered: 03/20/2018) (2) |
| Mar 19, 2018 | 267 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Leave to File Document Under Seal)(Takahashi, Heather Emily) (Entered: 03/19/2018) (0) |
| Mar 19, 2018 | 268 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 267 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Reply in Support of Immunex's Motion to Strike Portions of Robinson Declaration, # 2 Declaration of Michael J. Taussig ISO Immunex's Reply)(Takahashi, Heather Emily) (Entered: 03/19/2018) (0) |
| Mar 16, 2018 | 266 | REPLY In Support of Motion NOTICE OF MOTION AND MOTION to Exclude Untimely Opinions of Immunex's Experts 227 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 03/16/2018) (11) |
| Mar 15, 2018 | 262 | NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 4/16/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Immunex's Brief In Support Of Motion to Stay Pending Inter Partes Review, # 2 Declaration of Vincent Y. Ling ISO Motion to Stay, # 3 Exhibit 1 to Ling Declaration, # 4 Proposed Order Granting Immunex's Motion to Stay Pending Inter Partes Review) (Takahashi, Heather Emily) (Entered: 03/15/2018) (0) |
| Mar 15, 2018 | 263 | The Court finds the following motion suitable for disposition without oral argument and vacates the MOTION to Exclude Untimely Opinions of Immunex's Experts filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. [ECF #227], set for hearing on March 26, 2018. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule.THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 03/15/2018) (0) |
| Mar 15, 2018 | 264 | REQUEST to Withdraw Docket No. 262 NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review 262 filed by Plaintiff and Counterclaim-Defendant Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Request to Withdraw Docket No. 262) (Takahashi, Heather Emily) (Entered: 03/15/2018) (0) |
| Mar 15, 2018 | 265 | ORDER GRANTING IMMUNEX AND AMGEN'S REQUEST to Withdraw Docket No. 262 264 by Judge S. James Otero: Document No. 262 shall be stricken from the record. (jp) (Entered: 03/15/2018) (2) |
| Mar 14, 2018 | 260 | ORDER GRANTING DEFENDANTS' APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Judge S. James Otero. (yl) (Entered: 03/14/2018) (2) |
| Mar 14, 2018 | 261 | ORDER GRANTING EFENDAN S' APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Judge S. James Otero: Upon considering Defendants' Application to File Under Seal, the Application is GRANTED. Defendants' Opposition to Immunex's Motion to Strike Portions of Robinson Declaration, the Declaration of William H. Robinson, Ph.D., M.D., In Support of Defendants' Opposition to Immunex's Motion to Strike Portions of Robinson Declaration and E~iibits 3 and 5 to the Declaration of John F. Garvish, II In Support of Defendants' Opposition to Immunex's Motion to Strike Portions of Robinson Declaration shall be filed under seal in their entirety. granting 257 APPLICATION to Seal Document (yl) (Entered: 03/14/2018) (2) |
| Mar 12, 2018 | 255 | APPLICATION to file document Reply in Support of Defendants' Motion to Exclude Untimely Opinions of Immunex's Experts under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 03/12/2018) (0) |
| Mar 12, 2018 | 256 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Reply in Support of Defendants' Motion to Exclude Untimely Opinions of Immunex's Experts under seal 255 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Reply in Support of Motion to Exclude Untimely Opinions of Immunex's Experts)(Garvish, John) (Entered: 03/12/2018) (0) |
| Mar 12, 2018 | 257 | APPLICATION to file document Opposition to Immunex's Motion to Strike Portions of Robinson Declaration under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Proposed Order)(Garvish, John) (Entered: 03/12/2018) (0) |
| Mar 12, 2018 | 258 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Opposition to Immunex's Motion to Strike Portions of Robinson Declaration under seal 257 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Opposition to Immunex's Motion to Strike Portions of Robinson Declaration, # 2 Unredacted Document Declaration of William H. Robinson, Ph.D., M.D., # 3 Unredacted Document Exhibit 3, # 4 Unredacted Document Exhibit 4, # 5 Unredacted Document Exhibit 5)(Garvish, John) (Entered: 03/12/2018) (0) |
| Mar 12, 2018 | 259 | OPPOSITION to NOTICE OF MOTION AND MOTION to Strike Portions of Robinson Declaration 236 (Public Version - Full Opposition Filed Under Seal) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Exhibit 1, # 3 Exhibit 2)(Garvish, John) (Entered: 03/12/2018) (0) |
| Mar 8, 2018 | 254 | NOTICE OF MOTION AND MOTION to Stay Case pending Inter Partes Review filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 4/16/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in Support of Motion to Stay, # 2 Declaration of Vincent Y. Ling in Support of Motion to Stay, # 3 Exhibit 1 to Ling Decl., # 4 Proposed Order Granting Motion to Stay) (Takahashi, Heather Emily) (Entered: 03/08/2018) (0) |
| Mar 7, 2018 | 253 | SEALED DOCUMENT Immunex's Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts re Order on Motion for Leave to File Document Under Seal, 252 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Vincent Ling In Support Of Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts, # 2 Exhibit B to Ling Declaration, # 3 Exhibit D to Ling Declaration, # 4 Exhibit G to Ling Declaration, # 5 Exhibit H to Ling Declaration)(Takahashi, Heather Emily) (Entered: 03/07/2018) (0) |
| Mar 6, 2018 | 252 | ORDER GRANTING IMMUNEX AND AMGEN'S APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 250 by Judge S. James Otero. The following documents shall be filed under seal: (1) Immunex's Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts; and (2) Declaration of Vincent Y. Ling in Support of Immunex's Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts, including Exhibits B, D, G, and H thereto. (lom) (Entered: 03/06/2018) (2) |
| Mar 5, 2018 | 249 | Opposition Immunex's Opposition re: NOTICE OF MOTION AND MOTION to Exclude Untimely Opinions of Immunex's Experts 227 Immunex's Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Vincent Y. Ling ISO Immunex's Opposition, # 2 Exhibit A to Ling Declaration, # 3 Exhibit B to Ling Declaration, # 4 Exhibit C to Ling Declaration, # 5 Exhibit D to Ling Declaration, # 6 Exhibit E to Ling Declaration, # 7 Exhibit F to Ling Declaration, # 8 Exhibit G to Ling Declaration, # 9 Exhibit H to Ling Declaration, # 10 Exhibit I to Ling Declaration)(Takahashi, Heather Emily) (Entered: 03/05/2018) (0) |
| Mar 5, 2018 | 250 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Leave to File Under Seal)(Takahashi, Heather Emily) (Entered: 03/05/2018) (0) |
| Mar 5, 2018 | 251 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 250 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Immunex's Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts, # 2 Declaration of Vincent Y Ling ISO Opposition to Defendants' Motion to Exclude Opinions of Immunex's Experts, # 3 Exhibit B, # 4 Exhibit D, # 5 Exhibit G, # 6 Exhibit H)(Attorney Gregory P Stone added to party Amgen Inc.(pty:cd))(Stone, Gregory) (Entered: 03/05/2018) (0) |
| Mar 1, 2018 | 248 | ORDER GRANTING JOINT APPLICATION TO EXTEND DEADLINES FOR PLAINTIFFS DAMAGESCONTENTIONS AND DEFENDANTS RESPONSES 247 by Judge S. James Otero: The Court modifies its scheduling order as follows (1) Immunexs damages contentions will be due on May 10, 2018; and (2) Defendants responsive damages contentions will be due on June 14, 2018. (lc) (Entered: 03/01/2018) (3) |
| Feb 28, 2018 | 247 | Joint APPLICATION for Enlargement of Time to File Plaintiff's Damages Contentions and Defendants' Responses filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order) (Garvish, John) (Entered: 02/28/2018) (0) |
| Feb 27, 2018 | 245 | ORDER GRANTING IN PART PLAINTIFF'S MOTION TO COMPEL 208 by Magistrate Judge Paul L. Abrams. SEE ORDER FOR DETAILS. (ch) (Entered: 02/27/2018) (12) |
| Feb 27, 2018 | 246 | IMMUNEX'S Brief In Support Of Claim Construction and Opposition to Defendants' Motion for Summary Judgment re NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 (Redacted Version) filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Redacted Document Immunex's Statement of Genuine Disputes of Material Fact, # 2 Declaration of Michael J. Taussig ISO Immunex's Opposition to Defendants' MSJ)(Takahashi, Heather Emily) (Entered: 02/27/2018) (0) |
| Feb 23, 2018 | 241 | SEALED DOCUMENT Brief ISO Claim Construction and Opposition to Defendants' Motion for Summary Judgment re Order on Motion for Leave to File Document Under Seal, 231 filed by Plaintiff Immunex Corporation, Counter Defendant Immunex Corporation. (Attachments: # 1 Immunex's Statement of Genuine Disputes of Material Fact, # 2 Exhibit A to Lo Declaration, # 3 Exhibit B to Lo Declaration, # 4 Declaration of Michael J. Taussig ISO Immunex's Opposition to Defendants' Motion for Summary Judgment, # 5 Exhibit 39 to Taussig Declaration, # 6 Exhibit 40 to Taussig Declaration, # 7 Exhibit 41 to Taussig Declaration, # 8 Exhibit 42 to Taussig Declaration, # 9 Exhibit 45 to Taussig Declaration)(Takahashi, Heather Emily) (Entered: 02/23/2018) (0) |
| Feb 23, 2018 | 242 | SEALED DOCUMENT Brief ISO Motion to Strike Portions of Robinson Declaration re Order on Motion for Leave to File Document Under Seal 239 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.(Takahashi, Heather Emily) (Entered: 02/23/2018) (0) |
| Feb 23, 2018 | 243 | ORDER by Judge S. James Otero: Granting 235 Non-Resident Attorney Carly Romanowicz APPLICATION to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation and Amgen Inc., designating Gregory P. Stone as local counsel. (bm) (Entered: 02/23/2018) (1) |
| Feb 22, 2018 | 239 | ORDER GRANTING Immunex and Amgen Application for Leave to File Under Seal Immunex Brief in support of Motion to Strike Portions of Robinson Declaration 237 by Judge S. James Otero. (jp) (Entered: 02/22/2018) (2) |
| Feb 22, 2018 | 240 | TEXT ONLY ENTRY (In Chambers) by Magistrate Judge Paul L. Abrams. The Court has determined that oral argument will not be of material assistance in determining plaintiff's Motion to Compel Lakepharma Documents and Witnesses (ECF No. 208 ). Accordingly, the hearing noticed for February 28, 2018, is ORDERED OFF CALENDAR. The Motion is under submission. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ch) TEXT ONLY ENTRY (Entered: 02/22/2018) (0) |
| Feb 21, 2018 | 235 | APPLICATION of Non-Resident Attorney Carly Romanowicz to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21291649) filed by Pla intiff and Counterclaim Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order) (Takahashi, Heather Emily) (Entered: 02/21/2018) (0) |
| Feb 21, 2018 | 236 | NOTICE OF MOTION AND MOTION to Strike Portions of Robinson Declaration filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 4/2/2018 at 10:00 AM before Judge S. James Otero. (Takahashi, Heather Emily) (Entered: 02/21/2018) (4) |
| Feb 21, 2018 | 237 | APPLICATION to file document Immunex's Brief In Support of Motion to Strike Portions of Robinson Declaration under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Application for Leave to File Under Seal Immunex's Brief ISO Motion to Strike Portions of Robinson Decl.)(Takahashi, Heather Emily) (Entered: 02/21/2018) (0) |
| Feb 21, 2018 | 238 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Immunex's Brief In Support of Motion to Strike Portions of Robinson Declaration under seal 237 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Immunex's Brief ISO Motion to Strike Portions of Robinson Declaration)(Takahashi, Heather Emily) (Entered: 02/21/2018) (0) |
| Feb 20, 2018 | 231 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RELATING TO IMMUNEXS BRIEF IN SUPPORT OF CLAIM CONSTRUCTION AND OPPOSITION TO DEFENDANTS' MOTION FOR SUMMARY JUDGMENT by Judge S. James Otero granting 222 APPLICATION to Seal Document (yl) (Entered: 02/20/2018) (2) |
| Feb 20, 2018 | 232 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Judge S. James Otero: Upon considering Defendants Application to File Under Seal, the Application is GRANTED. The Memorandum of Points and Authorities in Support of Defendants Motion to Exclude Untimely Opinions of Immunexs Experts and Exhibits 2 and 6 to the Declaration of John F. Garvish, II in Support of Defendants Motion shall be filed under seal in its entirety.granting 228 APPLICATION to Seal Document (yl) (Entered: 02/20/2018) (2) |
| Feb 20, 2018 | 233 | NOTICE of Institution of Inter Partes Review of U.S. Patent No. 8,679,487 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Garvish, John) (Entered: 02/20/2018) (0) |
| Feb 20, 2018 | 234 | MINUTES (IN CHAMBERS) by Judge S. James Otero: DENYING 226 EX PARTE APPLICATION to Expedite Briefing on Defendant's Motion to Exclude Untimely Opinions of Immunex's Experts. The Court sets the following schedule. Defendants' MSJ/Markman Reply March 23, 2018. Plaintiff's MSJ/Markman Sur-reply April 6, 2018. MSJ/Markman Hearing April 27, 2018. (shb) (Entered: 02/20/2018) (1) |
| Feb 16, 2018 | 226 | EX PARTE APPLICATION to Expedite Briefing on Defendant's Motion to Exclude Untimely Opinions of Immunex's Experts filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order) (Garvish, John) (Entered: 02/16/2018) (0) |
| Feb 16, 2018 | 227 | NOTICE OF MOTION AND MOTION to Exclude Untimely Opinions of Immunex's Experts filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 3/26/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Exhibit 1, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Proposed Order) (Garvish, John) (Entered: 02/16/2018) (0) |
| Feb 16, 2018 | 228 | APPLICATION to file document Memorandum of Points and Authorities in Support of Defendants' Motion to Exclude Untimely Opinions of Immunex's Experts under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 02/16/2018) (0) |
| Feb 16, 2018 | 229 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Memorandum of Points and Authorities in Support of Defendants' Motion to Exclude Untimely Opinions of Immunex's Experts under seal 228 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Memorandum of Points and Authorities, # 2 Unredacted Document Exhibit 2, # 3 Unredacted Document Exhibit 6)(Garvish, John) (Entered: 02/16/2018) (0) |
| Feb 16, 2018 | 230 | OPPOSITION to EX PARTE APPLICATION to Expedite Briefing on Defendant's Motion to Exclude Untimely Opinions of Immunex's Experts 226 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 02/16/2018) (4) |
| Feb 15, 2018 | 222 | APPLICATION to file document Brief ISO Claim Construction and Opposition to Defendants' Motion for Summary Judgment under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Application for Leave to File Under Seal Documents)(Takahashi, Heather Emily) (Entered: 02/15/2018) (0) |
| Feb 15, 2018 | 223 | MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 and Claim Construction Brief filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Immunex's Additional Statement of Undisputed Material Facts, # 2 Declaration of Wan-Shon Lo ISO Immunex's Claim Construction and Opposition to Defendants' MSJ, # 3 Exhibit A to Lo Decl., # 4 Exhibit B to Lo Decl., # 5 Exhibit C to Lo Decl., # 6 Exhibit D to Lo Decl., # 7 Exhibit E to Lo Decl., # 8 Exhibit 36 to Taussig Decl., # 9 Exhibit 37 to Taussig Decl., # 10 Exhibit 38 to Taussig Decl., # 11 Exhibit 39 to Taussig Decl., # 12 Exhibit 40 to Taussig Decl., # 13 Exhibit 41 to Taussig Decl., # 14 Exhibit 42 to Taussig Decl., # 15 Exhibit 43 to Taussig Decl., # 16 Exhibit 44 to Taussig Decl., # 17 Exhibit 45 to Taussig Decl., # 18 Exhibit 46 to Taussig Decl., # 19 Exhibit 47 to Taussig Decl., # 20 Exhibit 48 to Taussig Decl., # 21 Exhibit 49 to Taussig Decl.)(Takahashi, Heather Emily) (Entered: 02/15/2018) (0) |
| Feb 15, 2018 | 224 | Notice of Appearance or Withdrawal of Counsel: for attorney Peter E Gratzinger counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Adding Peter E. Gratzinger as counsel of record for Plaintiff Immunex Corporation and Counterclaim-Defendants Immunex Corporation and Amgen Inc. for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counterclaim-Defendants Immunex Corporation and Amgen Inc.. (Attorney Peter E Gratzinger added to party Amgen Inc.(pty:cd), Attorney Peter E Gratzinger added to party Immunex Corporation(pty:pla), Attorney Peter E Gratzinger added to party Immunex Corporation(pty:cd))(Gratzinger, Peter) (Entered: 02/15/2018) (2) |
| Feb 15, 2018 | 225 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Brief ISO Claim Construction and Opposition to Defendants' Motion for Summary Judgment under seal 222 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Immunex's Brief ISO of Claim Construction and Opposition to Defendants' Motion for Summary Judgment, # 2 Unredacted Document Immunex's Statement of Genuine Disputes of Material Fact, # 3 Exhibit A to Lo Decl., # 4 Exhibit B to Lo Decl., # 5 Declaration of Michael J. Taussig, PH.D., ISO Immunex's Opposition to Defendant's MSJ, # 6 Exhibit 39 to Taussig Decl., # 7 Exhibit 40 to Taussig Decl., # 8 Exhibit 41 to Taussig Decl., # 9 Exhibit 42 to Taussig Decl., # 10 Exhibit 45 to Taussig Decl.)(Takahashi, Heather Emily) (Entered: 02/15/2018) (0) |
| Feb 12, 2018 | 221 | MEMORANDUM in Opposition to MOTION to Compel LakePharma Documents and Witnesses 208 Supplemental Memorandum in Support of Defendants' Opposition filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of Geoffrey L. Smith, # 2 Declaration of William H. Robinson, Ph.D., M.D.)(Garvish, John) (Entered: 02/12/2018) (0) |
| Feb 9, 2018 | 219 | SEALED DOCUMENT Joint Stipulation Regarding Immunex's Motion to Compel LakePharma Documents and Witnesses re Order on Motion for Leave to File Document Under Seal 213 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit 3 to Ling Decl. ISO Joint Stipulation, # 2 Exhibit 4 to Ling Decl., # 3 Exhibit 5 to Ling Decl., # 4 Exhibit 6 to Ling Decl., # 5 Exhibit 15 to Ling Decl., # 6 Exhibit A to Lelutiu Decl., # 7 Exhibit G to Lelutiu Decl., # 8 Exhibit H to Lelutiu Decl., # 9 Exhibit I to Lelutiu Decl.)(Takahashi, Heather Emily) (Entered: 02/09/2018) (0) |
| Feb 9, 2018 | 220 | MEMORANDUM in Support of MOTION to Compel LakePharma Documents and Witnesses 208 Supplemental Memorandum of Law filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 02/09/2018) (8) |
| Feb 7, 2018 | 217 | MINUTES (in chambers): ORDER GRANTING IN PART PLAINTIFF'S MOTION FOR EXTENSION 205 by Judge S. James Otero. Having considered the parties' arguments, the Court ORDERS that the parties adhere to the following extended briefing schedule: Plaintiff's Joint MSJ Opposition/Markman Brief February 15, 2018; Defendants' Reply February 22, 2018;Plaintiff's Sur-reply March 1, 2018. If Plaintiff's pending Motion to Compel [ECF No. 208] is granted, Plaintiff may renew the instant Motion and request supplemental briefing on any relevant issues raised by newly acquired discovery. Any other issues raised in the parties' briefings will be considered upon filing of a properly noticed motion to the Court. IT IS SO ORDERED. (lom) (Entered: 02/07/2018) (1) |
| Feb 7, 2018 | 218 | MINUTE ORDER IN CHAMBERS by Magistrate Judge Paul L. Abrams. On January 29, 2018, the Court issued an Order in which it granted in part and denied in part plaintiff's January 16, 2018, motion to compel ("January Motion"). (ECF No. 199 ). On February 5, 2018, the parties filed a Joint Request for Clarification of the Court's Order ("Joint Request"). (ECF No. 214 ). NO LATER THAN FEBRUARY 14, 2018, defendants shall provide (1) a declaration from Dr. Robinson AND a declaration from defendants' counsel, UNDER PENALTY OF PERJURY, that no documents that Dr. Robinson considered or reviewed in formulating the opinions set forth in Dr. Robinson's Declaration -- including documents relating to dupilumab and/or other IL-4R antibodies -- remain to be produced; and (2) a declaration from defendants' counsel, UNDER PENALTY OF PERJURY, that irrespective of whether Dr. Robinson actually considered them, no Analytical Documents generated by defendants during their 11-year-long research and development of dupimulab and/or other IL-4R antibodies that were reviewed by Dr. Robinson remain to be produced. SEE ORDER FOR DETAILS. (ch) (Entered: 02/07/2018) (4) |
| Feb 6, 2018 | 215 | MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION for Extension of Time to File Markman/Summary Judgment Briefing 205 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Exhibit A to Decl. of John F. Garvish, II, # 3 Exhibit B to Decl. of John F. Garvish, II, # 4 Exhibit C to Decl. of John F. Garvish, II, # 5 Exhibit D to Decl. of John F. Garvish, II, # 6 Proposed Order)(Garvish, John) (Entered: 02/06/2018) (0) |
| Feb 6, 2018 | 216 | REPLY Immunex's Reply in Support of Motion to Extend Schedule for Markman and Summary Judgment Briefing NOTICE OF MOTION AND MOTION for Extension of Time to File Markman/Summary Judgment Briefing 205 Immunex's Reply in Support of Motion to Extend Schedule for Markman and Summary Judgment Briefing filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit Exhibit 1 to Takahashi Declaration)(Takahashi, Heather Emily) (Entered: 02/06/2018) (0) |
| Feb 5, 2018 | 213 | ORDER GRANTING IMMUNEX AND AMGEN'S APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Magistrate Judge Paul L. Abrams. 209 (ch) (Entered: 02/05/2018) (2) |
| Feb 5, 2018 | 214 | Joint Request for Clarification filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation re: Order on Motion to Compel, 199 (Takahashi, Heather Emily) (Entered: 02/05/2018) (9) |
| Feb 5, 2018 | 244 | NOTICE OF LODGING (lodged CD )filed by plaintiff Immunex Corporation (lc) (Entered: 02/26/2018) (2) |
| Feb 2, 2018 | 207 | TEXT ONLY ENTRY ORDER by Judge S. James Otero: The Court is in receipt of Plaintiff's Motion to Extend Schedule for Markman/Summary Judgment Briefing [ECF No. 205]. Given that the Immunex's briefing deadline is approaching shortly, the Court finds that a condensed briefing schedule is warranted. The parties are strongly encouraged to come to an agreement on the matter of an extension and file a stipulation to the Court that is amenable to both parties. If no agreement can be reached, Defendants must file an Opposition on or before February 6, 2018 with a particular emphasis on any prejudice to Defendants if such an extension were to be granted. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vv) (Entered: 02/02/2018) (0) |
| Feb 2, 2018 | 208 | NOTICE OF MOTION AND MOTION to Compel LakePharma Documents and Witnesses filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 2/28/2018 at 10:00 AM before Magistrate Judge Paul L. Abrams. (Attachments: # 1 Declaration of Vincent Y. Ling ISO of Joint Stipulation Regarding Immunex's Motion to Compel LakePharma Documents and Witnesses, # 2 Exhibit 1 to Ling Decl., # 3 Exhibit 2 to Ling Decl., # 4 Exhibit 3 to Ling Decl., # 5 Exhibit 4 to Ling Decl., # 6 Exhibit 5 to Ling Decl., # 7 Exhibit 6 to Ling Decl., # 8 Exhibit 7 to Ling Decl., # 9 Exhibit 8 to Ling Decl., # 10 Exhibit 9 to Ling Decl., # 11 Exhibit 10 to Ling Decl., # 12 Exhibit 11 to Ling Decl., # 13 Exhibit 12 to Ling Decl., # 14 Exhibit 13 to Ling Decl., # 15 Exhibit 14 to Ling Decl., # 16 Exhibit 15 to Ling Decl., # 17 Declaration of Radu A. Lelutiu, # 18 Exhibit A to Lelutiu Decl., # 19 Exhibit B to Lelutiu Decl., # 20 Exhibit C to Lelutiu Decl., # 21 Exhibit D to Lelutiu Decl., # 22 Exhibit E to Lelutiu Decl., # 23 Exhibit F to Lelutiu Decl., # 24 Exhibit G to Lelutiu Decl., # 25 Exhibit H to Lelutiu Decl., # 26 Exhibit I to Lelutiu Decl., # 27 Declaration of William H. Robinson, Ph.D., M.D., # 28 Proposed Order Granting Immunex's Motion to Compel LakePharma Documents and Witnesses)(Takahashi, Heather Emily) (Entered: 02/02/2018) (0) |
| Feb 2, 2018 | 209 | APPLICATION to file document Joint Stipulation and Documents re Motion to Compel LakePharma Documents and Witnesses under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 02/02/2018) (0) |
| Feb 2, 2018 | 210 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Joint Stipulation and Documents re Motion to Compel LakePharma Documents and Witnesses under seal 209 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Joint Stipulation Regarding Immunex's Motion to Compel LakePharma Documents and Witnesses, # 2 Exhibit 3 to Ling Decl. ISO Joint Stipulation, # 3 Exhibit 4 to Ling Decl. ISO Joint Stipulation, # 4 Exhibit 5 to Ling Decl. ISO Joint Stipulation, # 5 Exhibit 6 to Ling Decl. ISO Joint Stipulation, # 6 Exhibit 15 to Ling Decl. ISO Joint Stipulation, # 7 Exhibit A to Lelutiu Decl., # 8 Exhibit G to Lelutiu Decl., # 9 Exhibit H to Lelutiu Decl., # 10 Exhibit I to Lelutiu Decl.)(Takahashi, Heather Emily) (Entered: 02/02/2018) (0) |
| Feb 2, 2018 | 211 | NOTICE of Manual Filing filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation of Exh 15 to Ling Decl iso Immunex's Motion to Compel to LakePharma Documents and Witnesses (DVD with video clips). (Takahashi, Heather Emily) (Entered: 02/02/2018) (1) |
| Feb 2, 2018 | 212 | NOTICE of Appeal of the European Patent Office's Decision Regarding European Patent No. EP 2292665 filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Exhibit A)(Takahashi, Heather Emily) (Entered: 02/02/2018) (0) |
| Feb 1, 2018 | 205 | NOTICE OF MOTION AND MOTION for Extension of Time to File Markman/Summary Judgment Briefing filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 3/5/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order Granting Motion to Extend Schedule for Markman/Summary Judgment Briefing) (Takahashi, Heather Emily) (Entered: 02/01/2018) (0) |
| Feb 1, 2018 | 206 | STATEMENT of Compliance filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC re: Order on Motion to Compel, 199 . (Garvish, John) (Entered: 02/01/2018) (8) |
| Jan 31, 2018 | 203 | SEALED DOCUMENT Combined Claim Construction Brief and Memorandum of Points and Authorities ISO of Defendants' Motion for Summary Judgment re NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 , Order on Motion for Leave to File Document Under Seal 197 , Order on Motion for Leave to File Document Under Seal 196 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Statement of Undisputed Facts and Conclusions of Law, # 2 Unredacted Document Exhibit 5)(Garvish, John) (Entered: 01/31/2018) (0) |
| Jan 31, 2018 | 204 | MEMORANDUM in Support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity 192 (Redacted Version) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Statement of Undisputed Facts and Conclusions of Law, # 2 Exhibit 3)(Garvish, John) (Entered: 01/31/2018) (0) |
| Jan 30, 2018 | 200 | SEALED DOCUMENT Joint Stipulation Regarding Immunex's Motion to Compel re Sealed Declaration in SupportDeclaration,,,, 172 , Order on Motion for Leave to File Document Under Seal 182 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Exhibit 4 to Ling Decl., # 2 Unredacted Document Exhibit 7 to Ling Decl., # 3 Unredacted Document Exhibit 8 to Ling Decl., # 4 Unredacted Document Exhibit 10 to Ling Decl., # 5 Unredacted Document Declaration of Radu A. Lelutiu, # 6 Unredacted Document Exhibit E to Lelutiu Decl.)(Garvish, John) (Entered: 01/30/2018) (0) |
| Jan 30, 2018 | 201 | JOINT STIPULATION to Corrected MOTION to Compel Production of Documents 174 (Redacted Version) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit 4 to Ling Decl., # 2 Exhibit 7 to Ling Decl., # 3 Exhibit 8 to Ling Decl., # 4 Exhibit 9 to Ling Decl., # 5 Exhibit 10 to Ling Decl., # 6 Declaration of Radu A. Lelutiu, # 7 Exhibit D to Lelutiu Decl., # 8 Exhibit E to Lelutiu Decl.)(Garvish, John) (Entered: 01/30/2018) (0) |
| Jan 30, 2018 | 202 | SUPPLEMENT to Corrected MOTION to Compel Production of Documents 174 Supplemental Memorandum of Law filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 01/30/2018) (11) |
| Jan 29, 2018 | 199 | ORDER GRANTING IN PART PLAINTIFF'S MOTION TO COMPEL by Magistrate Judge Paul L. Abrams. The hearing scheduled for January 31, 2018, is ORDERED OFF CALENDAR. Plaintiff's Motion 174 is GRANTED IN PART and DENIED IN PART. SEE ORDER FOR DETAILS. (ch) (Entered: 01/29/2018) (12) |
| Jan 26, 2018 | 194 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Vincent Ling ISO Immunex and Amgen's Application for Leave to File Documents Under Seal, # 2 Proposed Order Granting Immunex and Amgen's Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 01/26/2018) (0) |
| Jan 26, 2018 | 195 | Joint APPLICATION to Exceed Page Limitation Markman and Summary Judgment Briefing filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting the Joint Application to Exceed Page Limits) (Takahashi, Heather Emily) (Entered: 01/26/2018) (0) |
| Jan 26, 2018 | 196 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 190 by Judge S. James Otero (lc) (Entered: 01/29/2018) (3) |
| Jan 26, 2018 | 197 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 194 by Judge S. James Otero (lc) (Entered: 01/29/2018) (3) |
| Jan 26, 2018 | 198 | ORDER GRANTING JOINT APPLICATION TO EXCEED PAGE LIMITS FOR MARKMAN ANDSUMMARY JUDGMENT BRIEFING 195 by Judge S. James Otero (lc) (Entered: 01/29/2018) (2) |
| Jan 25, 2018 | 190 | APPLICATION to file document Defendants' Memorandum of Points and Authorities in Support of Defendants' Claim Construction Brief and Motion for Summary Judgment and Exhibits 3 and 5 under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Garvish, John) (Entered: 01/25/2018) (0) |
| Jan 25, 2018 | 191 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Defendants' Memorandum of Points and Authorities in Support of Defendants' Claim Construction Brief and Motion for Summary Judgment and Exhibits 3 and 5 under seal 190 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Combined Claim Construction Brief and Memorandum of Points and Authorities in Support of Defendants' Motion for Summary Judgment, # 2 Unredacted Document Exhibit 3, # 3 Unredacted Document Exhibit 5)(Garvish, John) (Entered: 01/25/2018) (0) |
| Jan 25, 2018 | 192 | NOTICE OF MOTION AND MOTION for Summary Judgment as to Invalidity filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 3/12/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 SEALED DOCUMENT-Statement of Undisputed Facts and Conclusions of Law, # 2 Declaration of John F. Garvish, II, # 3Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 4, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Proposed Order) (Garvish, John) Modified on 1/26/2018 (lc). Modified on 1/26/2018 (lc). (Entered: 01/25/2018) (0) |
| Jan 25, 2018 | 193 | TEXT ONLY ENTRY (In Chambers) by Magistrate Judge Paul L. Abrams. The in-person hearing set for January 31, 2018, on plaintiff's Motion to Compel (ECF No. 174 ) is hereby VACATED. Instead, unless the Motion is taken under submission prior to January 31, 2018, the hearing will be conducted telephonically. Counsel shall contact the courtroom deputy for call-in information. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ch) TEXT ONLY ENTRY (Entered: 01/25/2018) (0) |
| Jan 24, 2018 | 188 | ORDER GRANTING DEFENDANTS' APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL by Magistrate Judge Paul L. Abrams. Upon considering Defendants' Application to File Under Seal 187 , the following documents shall be filed under seal: Immunex's Supplemental Memorandum of Law in Support of the Motion to Compel (Dkt. No. 179-1) and Exs. 12 and 13 to the Ling Declaration ISO Immunex's Supplemental Memorandum of Law (Dkt. Nos. 179-2, -3). In addition, Defendants shall file public versions of these documents with references to CONFIDENTIAL information redacted. IT IS SO ORDERED. (ch) (Entered: 01/24/2018) (2) |
| Jan 24, 2018 | 189 | SEALED DOCUMENT Immunex's Supplemental Memorandum of Law re Corrected MOTION to Compel Production of Documents 174 , Order on Motion for Leave to File Document Under Seal,, 188 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit 12 to Ling Decl. ISO Immunex's Supplemental Memorandum, # 2 Exhibit 13 to Ling Decl. ISO Immunex's Supplemental Memorandum)(Takahashi, Heather Emily) (Entered: 01/24/2018) (0) |
| Jan 23, 2018 | 187 | APPLICATION to file document Immunex's Supplemental Memorandum of Law in Support of Motion to Compel and Exhibits 12 and 13 (Dkt Nos. 179-1, -2, -3) under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Proposed Order)(Garvish, John) (Entered: 01/23/2018) (0) |
| Jan 18, 2018 | 182 | ORDER GRANTING DEFENDANTS' APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEASL by Magistrate Judge Paul L. Abrams. SEE ORDER FOR SPECIFICS. 173 (ch) (Entered: 01/18/2018) (2) |
| Jan 18, 2018 | 183 | ORDER DENYING AS MOOT IMMUNEX and AMGEN'S APPLICATION 171 FOR LEAVE TO FILE DOCUMENTS UNDER SEAL in light of ECF No. 173 by Magistrate Judge Paul L. Abrams. (ch) (Entered: 01/18/2018) (3) |
| Jan 18, 2018 | 184 | ORDER GRANTING IMMUNEX AND AMGEN'S REQUEST TO WITHDRAW DOCKET NOS. 169 AND 170 by Magistrate Judge Paul L. Abrams. 175 (ch) (Entered: 01/18/2018) (2) |
| Jan 18, 2018 | 185 | ORDER GRANTING IMMUNEX AND AMGEN'S APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 177 by Magistrate Judge Paul L. Abrams. (ch) (Entered: 01/18/2018) (2) |
| Jan 18, 2018 | 186 | ORDER DENYING DEFENDANTS' MOTION TO MODIFY PROTECTIVE ORDER 168 by Magistrate Judge Paul L. Abrams. The hearing scheduled for January 31, 2018, is ORDERED OFF CALENDAR. SEE ORDER FOR FURTHER DETAILS. (ch) (Entered: 01/18/2018) (5) |
| Jan 17, 2018 | 175 | Request to Withdraw filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation Request to Withdraw Docket Nos. 169 and 170 (Attachments: # 1 Proposed Order Granting Immunex and Amgen's Request to Withdraw)(Takahashi, Heather Emily) (Entered: 01/17/2018) (0) |
| Jan 17, 2018 | 176 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Amgen Inc., Immunex Miscellaneous Document, 175 . The following error(s) was/were found: Incorrect event selected. Correct event to be used is: Request: order. Other error(s) with document(s): Note: to narrow the selection process Note: To assist in a search for correct events, please use the "SEARCH" option for a "key word". The incorrect event does not provide any relief as sought.. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 01/17/2018) (2) |
| Jan 17, 2018 | 177 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 01/17/2018) (0) |
| Jan 17, 2018 | 178 | SUPPLEMENT to NOTICE OF MOTION AND MOTION to Amend Stipulation for Protective Order 108 168 Supplemental Memorandum of Law filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Exhibit A)(Garvish, John) (Entered: 01/17/2018) (0) |
| Jan 17, 2018 | 179 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 177 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Memorandum of Law ISO Immunex's Motion to Compel, # 2 Exhibit 12 to Ling Decl. ISO Immunex's Supplemental Memorandum of Law, # 3 Exhibit 13 to Ling Decl. ISO Immunex's Supplemental Memorandum of Law)(Takahashi, Heather Emily) (Entered: 01/17/2018) (0) |
| Jan 17, 2018 | 180 | SUPPLEMENT to Corrected MOTION to Compel Production of Documents 174 Supplemental Memorandum filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of Radu A. Lelutiu, # 2 Exhibit F)(Garvish, John) (Entered: 01/17/2018) (0) |
| Jan 17, 2018 | 181 | DECLARATION of Vincent Y. Ling in support of Corrected MOTION to Compel Production of Documents 174 Supplemental Memorandum of Law filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit 11 to Ling Decl. ISO Immunex's Supplemental Memorandum re Motion to Compel, # 2 Exhibit 12 to Ling Decl. ISO Immunex's Supplemental Memorandum re Motion to Compel, # 3 Exhibit 13 to Ling Decl. ISO Immunex's Supplemental Memorandum re Motion to Compel)(Takahashi, Heather Emily) (Entered: 01/17/2018) (0) |
| Jan 16, 2018 | 173 | APPLICATION to file document Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents and Related Filings under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration Radu A. Lelutiu, # 2 Proposed Order)(Garvish, John) (Entered: 01/16/2018) (0) |
| Jan 16, 2018 | 174 | NOTICE OF MOTION AND Corrected MOTION to Compel Production of Documents filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. Motion set for hearing on 1/31/2018 at 10:00 AM before Magistrate Judge Paul L. Abrams. (Attachments: # 1 Declaration Vincent Y. Ling ISO Joint Stipulation Re Immunex's Motion to Compel, # 2 Exhibit 1 to Ling Decl., # 3 Exhibit 2 to Ling Decl., # 4 Exhibit 3 to Ling Decl., # 5 Exhibit 4 to Ling Decl., # 6 Exhibit 5 to Ling Decl., # 7 Exhibit 6 to Ling Decl., # 8 Exhibit 7 to Ling Decl., # 9 Exhibit 8 to Ling Decl., # 10 Exhibit 9 to Ling Decl., # 11 Exhibit 10 to Ling Decl., # 12 Declaration of Radu A. Lelutiu, # 13 Exhibit A to Lelutiu Decl., # 14 Exhibit B to Lelutiu Decl., # 15 Exhibit C to Lelutiu Decl., # 16 Proposed Order Granting Motion to Compel)(Takahashi, Heather Emily) (Entered: 01/16/2018) (0) |
| Jan 12, 2018 | 170 | WITHDRAWN - SEE ENTRY NO. 184 - APPLICATION for Leave to file Documents Under Seal filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order Granting Application for Leave to File Documents Under Seal) (Takahashi, Heather Emily) Modified on 1/18/2018 (ch). (Entered: 01/12/2018) (0) |
| Jan 12, 2018 | 171 | APPLICATION to file document under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order Granting Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 01/12/2018) (0) |
| Jan 12, 2018 | 172 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 171 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Unredacted Document Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents, # 2 Exhibit 4 to Ling Decl. ISO Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents, # 3 Exhibit 7 to Ling Decl. ISO Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents, # 4 Exhibit 8 to Ling Decl. ISO Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents, # 5 Exhibit 9 to Ling Decl. ISO Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents, # 6 Exhibit 10 to Ling Decl. ISO Joint Stipulation Regarding Immunex's Motion to Compel Production of Documents, # 7 Declaration of Radu A. Lelutiu, # 8 Exhibit D to Lelutiu Decl., # 9 Exhibit E to Lelutiu Decl.)(Takahashi, Heather Emily) (Entered: 01/12/2018) (0) |
| Jan 9, 2018 | 168 | NOTICE OF MOTION AND MOTION to Amend Stipulation for Protective Order 108 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 1/31/2018 at 10:00 AM before Magistrate Judge Paul L. Abrams. (Attachments: # 1 Joint Stipulation, # 2 Appendix A - Proposed 1st Amended Protective Order, # 3 Declaration of John F. Garvish, II, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C, # 7 Exhibit D, # 8 Exhibit E, # 9 Exhibit F, # 10 Exhibit G, # 11 Exhibit H, # 12 Proposed Order) (Garvish, John) (Entered: 01/09/2018) (0) |
| Jan 5, 2018 | 167 | NOTICE of Decision: European Patent Office's Written Decision Revoking The European Counterpart To The Patent In Suit filed by Defendants Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A)(Garvish, John) (Entered: 01/05/2018) (0) |
| Jan 4, 2018 | 166 | DECLARATION of William H. Robinson, Ph.D., M.D. re Declaration,,,, 153 (Redacted Version) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 01/04/2018) (30) |
| Dec 20, 2017 | 165 | SEALED DOCUMENT Declaration of Dr. William Robinson re APPLICATION to file document Appendix C and Exhibits 47 and 48 to the Declaration of Dr. William Robinson under seal 159 , APPLICATION to file document Declaration of Dr. William Robinson, Appendix D, and Exhibits 28, 29, 31, 33, 34, 44 and 45 under seal 154 , Sealed Declaration in SupportDeclaration, 156 , Sealed Declaration in SupportDeclaration, 160 , Order on Motion for Leave to File Document Under Seal 163 , Order on Motion for Leave to File Document Under Seal 164 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Appendix C, # 2 Appendix D, # 3 Exhibit 28, # 4 Exhibit 29, # 5 Exhibit 31, # 6 Exhibit 33, # 7 Exhibit 34, # 8 Exhibit 44, # 9 Exhibit 45, # 10 Exhibit 47, # 11 Exhibit 48)(Garvish, John) (Entered: 12/20/2017) (0) |
| Dec 13, 2017 | 163 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 154 by Judge S. James Otero (lc) (Entered: 12/14/2017) (2) |
| Dec 13, 2017 | 164 | ORDER GRANTING DEFENDANTS APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 159 by Judge S. James Otero (lc) (Entered: 12/14/2017) (2) |
| Dec 12, 2017 | 159 | APPLICATION to file document Appendix C and Exhibits 47 and 48 to the Declaration of Dr. William Robinson under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Declaration of John F. Garvish, II)(Garvish, John) (Entered: 12/12/2017) (0) |
| Dec 12, 2017 | 160 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Appendix C and Exhibits 47 and 48 to the Declaration of Dr. William Robinson under seal 159 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document - Appendix C, # 2 Unredacted Document - Exhibit 47, # 3 Unredacted Document - Exhibit 48)(Garvish, John) (Entered: 12/12/2017) (0) |
| Dec 12, 2017 | 161 | ORDER GRANTING PPLICATION of Non-Resident Attorney David Mlaver to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation and designating Gregory P Stone as local counsel 150 by Judge S. James Otero (lc) (Entered: 12/12/2017) (1) |
| Dec 12, 2017 | 162 | ORDER GRANTING APPLICATION of Non-Resident Attorney Wan-Shon Lo to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation and designating Gregory P Stone as local counsel 141 by Judge S. James Otero: (lc) (Entered: 12/12/2017) (1) |
| Dec 11, 2017 | 158 | Notice of Appearance or Withdrawal of Counsel: for attorney Heather Emily Fitzgerald Takahashi counsel for Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. Adding Ted G. Dane as counsel of record for Immunex Corporation and Amgen Inc. for the reason indicated in the G-123 Notice. Filed by Plaintiff and Counterclaim-Defendants Immunex Corporation and Amgen Inc.. (Takahashi, Heather Emily) (Entered: 12/11/2017) (2) |
| Dec 7, 2017 | 153 | DECLARATION of William H. Robinson, Ph.D., M.D. (Public Version - Full Declaration Filed Under Seal) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Appendix A, # 2 Appendix B, # 3 SEALED DOCUMENT-Appendix C, # 4 Appendix E, # 5 Exhibit 1, # 6 Exhibit 2, # 7 Exhibit 3, # 8 Exhibit 4, # 9 Exhibit 5, # 10 Exhibit 6, # 11 Exhibit 7, # 12 Exhibit 8, # 13 Exhibit 9, # 14 Exhibit 10, # 15 Exhibit 11, # 16 Exhibit 12, # 17 Exhibit 13, # 18 Exhibit 14, # 19 Exhibit 15, # 20 Exhibit 16, # 21 Exhibit 17, # 22 Exhibit 18, # 23 Exhibit 19, # 24 Exhibit 20, # 25 Exhibit 21, # 26 Exhibit 22, # 27 Exhibit 23, # 28 Exhibit 24, # 29 Exhibit 25, # 30 Exhibit 26, # 31 Exhibit 27, # 32 Exhibit 30, # 33 Exhibit 32, # 34 Exhibit 35, # 35 Exhibit 36, # 36 Exhibit 37, # 37 Exhibit 38, # 38 Exhibit 39, # 39 Exhibit 40, # 40 Exhibit 41, # 41 Exhibit 42, # 42 Exhibit 43, # 43 Exhibit 46, # 44 SEALED DOCUMENT-Exhibit 47, # 45SEALED DOCUMENT Exhibit 48, # 46 Exhibit 49)(Garvish, John) Modified on 12/14/2017 (lc). (Entered: 12/07/2017) (0) |
| Dec 7, 2017 | 154 | APPLICATION to file document Declaration of Dr. William Robinson, Appendix D, and Exhibits 28, 29, 31, 33, 34, 44 and 45 under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Declaration of John F. Garvish, II)(Garvish, John) (Entered: 12/07/2017) (0) |
| Dec 7, 2017 | 155 | DECLARATION of Michael J. Taussig, Ph.D. in Support of Immunex's Claim Constructions filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35)(Takahashi, Heather Emily) (Entered: 12/07/2017) (0) |
| Dec 7, 2017 | 156 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Declaration of Dr. William Robinson, Appendix D, and Exhibits 28, 29, 31, 33, 34, 44 and 45 under seal 154 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Appendix D, # 2 Exhibit 28, # 3 Exhibit 29, # 4 Exhibit 31, # 5 Exhibit 33, # 6 Exhibit 34, # 7 Exhibit 44, # 8 Exhibit 45)(Garvish, John) (Entered: 12/07/2017) (0) |
| Dec 7, 2017 | 157 | STATEMENT JOINT CLAIM CONSTRUCTION AND PREHEARING STATEMENT filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Takahashi, Heather Emily) (Entered: 12/07/2017) (30) |
| Dec 1, 2017 | 152 | NOTICE of the European Patent Office's Revocation of the European Counterpart to the Patent in Suit filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Garvish, John) (Entered: 12/01/2017) (0) |
| Nov 29, 2017 | 151 | ORDER GRANTING APPLICATION of Non-Resident Attorney David Mlaver to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation and designating Gregory P Stone as local counsel 147 by Judge S. James Otero (lc) (Entered: 11/29/2017) (1) |
| Nov 27, 2017 | 150 | APPLICATION of Non-Resident Attorney David Mlaver to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Pro Hac Vice Fee - $325.00 Previously Paid on 11/21/2017, Receipt No. 26651CUP) filed by Plaintiff and Counterclaim-Defendans Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order) (Takahashi, Heather Emily) (Entered: 11/27/2017) (0) |
| Nov 22, 2017 | 148 | NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney David Mlaver to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20863347) 147 . The following error(s) was/were found: Local Rule 83-2.1.3.3(d) Certificate of Good Standing not attached for every state court listed to which the applicant has been admitted. MD is missing. (lt) (Entered: 11/22/2017) (1) |
| Nov 22, 2017 | 149 | RESPONSE BY THE COURT TO NOTICE TO FILER OF DEFICIENCIES IN ELECTRONICALLY FILED DOCUMENTS RE: APPLICATION of Non-Resident Attorney David Mlaver to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20863347) 147 by Clerk of Court. Counsel is ordered to re-file the Application, correcting the deficiencies stated in the Notice to Filer of Deficiencies [ECF #148] by no later than December 6, 2017.. (lc) (Entered: 11/27/2017) (1) |
| Nov 21, 2017 | 147 | APPLICATION of Non-Resident Attorney David Mlaver to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20863347) filed by Plainti ffs and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney to Appear Pro Hac Vice) (Takahashi, Heather Emily) (Entered: 11/21/2017) (0) |
| Nov 17, 2017 | 146 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENT UNDER SEAL 142 by Judge S. James Otero (lc) (Entered: 11/17/2017) (3) |
| Nov 14, 2017 | 142 | APPLICATION to file document Answer to First Amended Counterclaims under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Sarah G. Boyce ISO Application for Leave to File Document Under Seal, # 2 Proposed Order Granting Application for Leave to File Document Under Seal)(Takahashi, Heather Emily) (Entered: 11/14/2017) (0) |
| Nov 14, 2017 | 143 | SEALED DOCUMENT Answer to First Amended Counterclaims re APPLICATION to file document Answer to First Amended Counterclaims under seal 142 , Sealed Document,,, 139 , Initial Order upon Filing of Complaint - form only 54 , Protective Order 109 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.(Takahashi, Heather Emily) (Entered: 11/14/2017) (0) |
| Nov 14, 2017 | 144 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Sealed Document (sealed answer to first amended counterclaim by Amgen Inc, Immunex Corporation, [ docket no. 143]. The following error(s) was/were found: Leave of court required for filing. Other error(s) with document(s): Filer filed before Judge has issued order. Sealed document should have been submitted as separate attachment to main document pending Judges ruling.. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 11/14/2017) (2) |
| Nov 14, 2017 | 145 | Amended APPLICATION to file document Answer to First Amended Counterclaims under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Sarah G. Boyce ISO Application for Leave to File Document Under Seal, # 2 Proposed Order Granting Application for Leave to File Document Under Seal, # 3 Redacted Document Answer to First Amended Counterclaims)(Takahashi, Heather Emily) (Entered: 11/14/2017) (0) |
| Nov 3, 2017 | 141 | APPLICATION of Non-Resident Attorney Wan-Shon Lo to Appear Pro Hac Vice on behalf of Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20775691) filed by Plaintif f and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order) (Takahashi, Heather Emily) (Entered: 11/03/2017) (0) |
| Oct 31, 2017 | 139 | SEALED DOCUMENT First Amended Answer re Order on Motion for Leave to File Document,, Order on Motion to Strike, 131 , Order on Motion for Leave to File Document Under Seal 97 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Exhibit 1, # 2 Unredacted Document Exhibit 2, # 3 Unredacted Document Exhibit 3, # 4 Unredacted Document Exhibit 4, # 5 Unredacted Document Exhibit 5, # 6 Unredacted Document Exhibit 6, # 7 Unredacted Document Exhibit 7, # 8 Unredacted Document Exhibit 8, # 9 Unredacted Document Exhibit 9, # 10 Unredacted Document Exhibit 10, # 11 Unredacted Document Exhibit 11, # 12 Unredacted Document Exhibit 12, # 13 Unredacted Document Exhibit 13, # 14 Unredacted Document Exhibit 14, # 15 Unredacted Document Exhibit 15)(Garvish, John) (Entered: 10/31/2017) (0) |
| Oct 31, 2017 | 140 | AMENDED ANSWER (Redacted) and First Amended Counterclaims to Complaint (Attorney Civil Case Opening), 1 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 10/31/2017) (30) |
| Oct 30, 2017 | 138 | MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER GRANTING DEFENDANTS' MOTION FOR ORDER OR BRIEFING SCHEDULE 128 .Completion of Claim Construction Discovery January 11, 2018; Defendants' Joint MSJ/Markman Brief January 25, 2018; Plaintiff's Joint MSJ Opposition/Markman Brief February 8, 2018;Defendants' Reply February 15, 2018; Plaintiff's Sur-reply February 22, 2018. (lc) (Entered: 10/30/2017) (2) |
| Oct 27, 2017 | 135 | APPLICATION to file document Immunex And Amgen's Application For Leave To File Document Under Seal under seal filed by Plaintiff Immunex Corporation, Counter Defendant Immunex Corporation. (Attachments: # 1 Declaration of Heather E. Takahashi In Support Of Immunex and Amgen's Application For Leave To File Document Under Seal, # 2 Proposed Order Granting Immunex And Amgen's Application For Leave To File Document Under Seal)(Takahashi, Heather Emily) (Entered: 10/27/2017) (0) |
| Oct 27, 2017 | 136 | SEALED DOCUMENT Exhibit B to Declaration of Sarah G. Boyce In Support Of Immunex an Amgen's Opposition to Defendants' Motion To Set Briefing Schedule re APPLICATION to file document Immunex And Amgen's Application For Leave To File Document Under Seal under seal 135 , Order on Motion for Leave to File Document Under Seal 129 filed by Plaintiff Immunex Corporation, Counter Defendant Immunex Corporation.(Takahashi, Heather Emily) (Entered: 10/27/2017) (0) |
| Oct 27, 2017 | 137 | OPPOSITION in opposition re: NOTICE OF MOTION AND MOTION for Order for Briefing Schedule 128 Immunex And Amgen's Memorandum Of Points And Authorities In Opposition To Defendants' Motion To Set Briefing Schedule filed by Plaintiff Immunex Corporation, Counter Defendant Immunex Corporation. (Attachments: # 1 Declaration of Sarah G. Boyce In Support Of Immunex an Amgen's Opposition to Defendants' Motion To Set Briefing Schedule, # 2 Exhibit A, # 3 Exhibit B)(Takahashi, Heather Emily) (Entered: 10/27/2017) (0) |
| Oct 26, 2017 | 134 | SUPPLEMENT to MOTION for Review of "Confidential" Designations of Certain Immunex Documents re 118 APPLICATION to file document under seal 119 - Supplemental Memorandum of Law (Redacted) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 10/26/2017) (10) |
| Oct 25, 2017 | 132 | SEALED DOCUMENT Supplemental Memorandum of Law in Support of Defendants' Motion Challenging "Confidential" Designations re Sealed Declaration in SupportDeclaration, 124 , Declaration (Motion related), 125 , Order on Motion for Leave to File Document Under Seal 129 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC.(Garvish, John) (Entered: 10/25/2017) (0) |
| Oct 25, 2017 | 133 | ORDER RE DEFENDANTS' MOTION CHALLENGING THE "CONFIDENTIAL" DESIGNATIONS OF CERTAIN IMMUNEX DOCUMENTS 119 by Magistrate Judge Paul L. Abrams. The hearing scheduled for November 1, 2017, is ORDERED OFF CALENDAR. Defendants' Motion for the Court to strike plaintiff's designation of the disputed documents as Confidential and to unseal those documents is DENIED. SEE ORDER FOR DETAILS. (ch) (Entered: 10/25/2017) (14) |
| Oct 24, 2017 | 130 | The Court is in receipt of Defendants' Motion for Order for Briefing Schedule filed on October 23, 2017 [ECF No. 128]. The Court VACATES the November 27, 2017 hearing date and ORDERS Plaintiff to file an Opposition on or before October 27, 2017. Defendants shall not file a Reply. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 10/24/2017) (0) |
| Oct 24, 2017 | 131 | MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER GRANTING DEFENDANTS' MOTION FOR LEAVE TO FILE FIRST AMENDED ANSWER 91 ; DENYING DEFENDANTS' MOTION TO STRIKE INFRINGEMENT CONTENTIONS AND COMPEL MORE DEFINITE DISCLOSURE 94 . Defendants shall file the First Amended Answer within 7 days of the issuance of this Order. (lc) (Entered: 10/24/2017) (6) |
| Oct 23, 2017 | 128 | NOTICE OF MOTION AND MOTION for Order for Briefing Schedule filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 11/27/2017 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum In Support of Motion, # 2 Declaration of John F. Garvish, II, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Proposed Order) (Garvish, John) (Entered: 10/23/2017) (0) |
| Oct 23, 2017 | 129 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILEDOCUMENTS UNDER SEAL 123 by Judge S. James Otero (lc) (Entered: 10/23/2017) (2) |
| Oct 18, 2017 | 123 | APPLICATION to file document Supplemental Brief in Support of Joint Stipulation Regarding Defendants' Motion Challenging The "Confidential" Designations of Certain Immunex Documents under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Heather E.Takahashi iso Application for Leave to File Documents Under Seal, # 2 Proposed Order Granting Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 10/18/2017) (0) |
| Oct 18, 2017 | 124 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Supplemental Brief in Support of Joint Stipulation Regarding Defendants' Motion Challenging The "Confidential" Designations of Certain Immunex Documents under seal 123 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC.(Garvish, John) (Entered: 10/18/2017) (0) |
| Oct 18, 2017 | 125 | DECLARATION of John F. Garvish, II in Support of APPLICATION to file document Supplemental Brief in Support of Joint Stipulation Regarding Defendants' Motion Challenging The "Confidential" Designations of Certain Immunex Documents under seal 123 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Garvish, John) (Entered: 10/18/2017) (0) |
| Oct 18, 2017 | 126 | JOINT STIPULATION to MOTION for Review of "Confidential" Designations of Certain Immunex Documents re 118 APPLICATION to file document under seal 119 (Redacted) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration Declaration of Emily C. Johnson (Redacted))(Garvish, John) (Entered: 10/18/2017) (0) |
| Oct 18, 2017 | 127 | SEALED DOCUMENT Joint Stipulation re MOTION for Review of "Confidential" Designations of Certain Immunex Documents re 118 APPLICATION to file document under seal 119 , Order on Motion for Leave to File Document Under Seal, 122 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration Declaration of Emily C. Johnson, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G, # 10 Exhibit H, # 11 Exhibit I)(Garvish, John) (Entered: 10/18/2017) (0) |
| Oct 12, 2017 | 121 | NOTICE of Update to the Joint Rule 26(f) Report filed by Plaintiffs and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Exhibit A)(Takahashi, Heather Emily) (Entered: 10/12/2017) (0) |
| Oct 12, 2017 | 122 | ORDER GRANTING IMMUNEX AND AMGEN'S APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 118 by Judge S. James Otero. IT IS HEREBY ORDERED that the application is GRANTED. The following documents and portions of documents shall be filed under seal pending disposition of the Motion for Review of "Confidential" Designations of Certain Immunex Documents 119 . See attached document. (lom) (Entered: 10/12/2017) (5) |
| Oct 11, 2017 | 119 | NOTICE OF MOTION AND MOTION for Review of "Confidential" Designations of Certain Immunex Documents re 118 APPLICATION to file document under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 11/1/2017 at 10:00 AM before Magistrate Judge Paul L. Abrams. (Attachments: # 1 Declaration of John F. Garvish, II, # 2 Exhibit A, # 3 Exhibit B, # 4 Declaration of Heather E. Takahashi, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Proposed Order)(Garvish, John) (Entered: 10/11/2017) (0) |
| Oct 11, 2017 | 120 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document under seal 118 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Declaration of Emily C. Johnson, # 2 Unredacted Document Exhibit 1, # 3 Unredacted Document Exhibit 2, # 4 Unredacted Document Exhibit 3, # 5 Declaration of John F. Garvish, II, # 6 Unredacted Document Exhibit C, # 7 Unredacted Document Exhibit D, # 8 Unredacted Document Exhibit E, # 9 Unredacted Document Exhibit F, # 10 Unredacted Document Exhibit G, # 11 Unredacted Document Exhibit H, # 12 Unredacted Document Exhibit I)(Garvish, John) (Entered: 10/11/2017) (0) |
| Oct 10, 2017 | 118 | APPLICATION to file document under seal filed by Counter Defendant Amgen Inc., Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Heather Takahashi ISO Immunex and Amgen's Application for Leave to File Documents Under Seal, # 2 Proposed Order Granting Immunex and Amgen's Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 10/10/2017) (0) |
| Oct 5, 2017 | 117 | The Court finds the following motions suitable for disposition without oral argument and vacates the MOTION for Leave to file First Amended Answer filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. [ECF #91] and the MOTION to Strike Infringement Contentions and Compel More Definite Disclosure filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis [ECF #94] set for hearing on October 16, 2017. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 10/05/2017) (0) |
| Oct 3, 2017 | 116 | REPLY In Support of Motion APPLICATION to file document Defendants' Reply Brief iso Defendants' Motion for Leave to File an Amended Answer and Counterclaim under seal 110 , APPLICATION to file document Reply in Support of Defendants' Motion for Leave to File First Amended Answer under seal 113 , NOTICE OF MOTION AND MOTION for Leave to file First Amended Answer 91 (Redacted) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 10/03/2017) (9) |
| Oct 2, 2017 | 111 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: APPLICATION to file document Defendants' Reply Brief iso Defendants' Motion for Leave to File an Amended Answer and Counterclaim under seal 110 . The following error(s) was/were found: Missing Redacted and Unredacted Documents. For Assistance refer to the Court website regarding Guide to E-filing sealed documents www.cacd.uscourts.gov/e-filing/sealed-documents In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 10/02/2017) (1) |
| Oct 2, 2017 | 112 | REPLY In Support of a Motion NOTICE OF MOTION AND MOTION to Strike Infringement Contentions and Compel More Definite Disclosure 94 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 10/02/2017) (9) |
| Oct 2, 2017 | 113 | APPLICATION to file document Reply in Support of Defendants' Motion for Leave to File First Amended Answer under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Declaration of John F. Garvish, II)(Garvish, John) (Entered: 10/02/2017) (0) |
| Oct 2, 2017 | 114 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Defendants' Reply Brief iso Defendants' Motion for Leave to File an Amended Answer and Counterclaim under seal 110 , APPLICATION to file document Reply in Support of Defendants' Motion for Leave to File First Amended Answer under seal 113 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC.(Garvish, John) (Entered: 10/02/2017) (0) |
| Oct 2, 2017 | 115 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENT UNDER SEAL 113 by Judge S. James Otero (lc) (Entered: 10/02/2017) (2) |
| Sep 29, 2017 | 109 | ORDER GRANTING STIPULATED PROTECTIVE ORDER by Magistrate Judge Paul L. Abrams. 108 (ch) (Entered: 09/29/2017) (2) |
| Sep 29, 2017 | 110 | APPLICATION to file document Defendants' Reply Brief iso Defendants' Motion for Leave to File an Amended Answer and Counterclaim under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Heather E. Takahashi iso Immunex and Amgen's Application For Leave to File Document Under Seal, # 2 Proposed Order Granting Application for Leave to File Document Under Seal)(Takahashi, Heather Emily) (Entered: 09/29/2017) (0) |
| Sep 28, 2017 | 106 | STRICKEN - SEE ENTRY NO. 107. STIPULATION for Protective Order filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation.(Takahashi, Heather Emily) Modified on 9/28/2017 (ch). (Entered: 09/28/2017) (30) |
| Sep 28, 2017 | 107 | TEXT ONLY ENTRY (In Chambers) by Magistrate Judge Paul L. Abrams. The parties filed a "Stipulated Protective Order" on September 28, 2017 (ECF No. 106 ). The document is ORDERED STRICKEN FROM THE RECORD. A proposed order is missing. Counsel shall refile the document with the proposed order submitted as an attachment to the Stipulation. A WordPerfect or Word version of the proposed order should be e-mailed to pla_chambers@cacd.uscourts.gov. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ch) TEXT ONLY ENTRY (Entered: 09/28/2017) (0) |
| Sep 28, 2017 | 108 | STIPULATION for Protective Order filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation. (Attachments: # 1 Proposed Order)(Takahashi, Heather Emily) (Entered: 09/28/2017) (0) |
| Sep 26, 2017 | 105 | ORDER GRANTING IMMUNEX AND AMGENS APPLICATION FOR LEAVE TO FILE DOCUMENT UNDER SEAL 103 by Judge S. James Otero (lc) (Entered: 09/26/2017) (2) |
| Sep 25, 2017 | 101 | REQUEST FOR JUDICIAL NOTICE iso Opposition to Defendants' Motion for Leave to Amend the Answer filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration Boyce Decl. iso of Request for Judicial Notice, # 2 Exhibit A to Boyce Decl. iso of Request for Judicial Notice, # 3 Proposed Order Granting Request for Judicial Notice)(Takahashi, Heather Emily) (Entered: 09/25/2017) (0) |
| Sep 25, 2017 | 102 | MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Strike Infringement Contentions and Compel More Definite Disclosure 94 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration of Heather Takahashi iso Opposition to Defendants' Motion to Strike Infringement and Contentions and Compel More Definite Disclosure, # 2 Exhibit A to Takahashi Decl., # 3 Exhibit B to Takahashi Decl.)(Takahashi, Heather Emily) (Entered: 09/25/2017) (0) |
| Sep 25, 2017 | 103 | APPLICATION to file document Opposition to Defendants' Motion For Leave to File An Amended Answer and Counterclaim under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration iso of Application for Leave to File Document Under Seal, # 2 Proposed Order Granting Application for Leave to File Document Under Seal, # 3 Redacted Document)(Takahashi, Heather Emily) (Entered: 09/25/2017) (0) |
| Sep 25, 2017 | 104 | SEALED DOCUMENT Immunex and Amgen's Opposition to Defendants' Motion for Leave to File an Amended Answer and Counterclaim re APPLICATION to file document Opposition to Defendants' Motion For Leave to File An Amended Answer and Counterclaim under seal 103 , NOTICE OF MOTION AND MOTION for Leave to file First Amended Answer 91 , Order on Motion for Leave to File Document Under Seal 97 filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.(Takahashi, Heather Emily) (Entered: 09/25/2017) (0) |
| Sep 22, 2017 | 99 | SEALED DOCUMENT Defendants' Memorandum of Points and Authorities in Support of Motion to File First Amended Answer re NOTICE OF MOTION AND MOTION for Leave to file First Amended Answer 91 , Order on Motion for Leave to File Document Under Seal, 98 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Appendix A - Amended Answer, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Appendix B - Redline of Amended Answer)(Garvish, John) (Entered: 09/22/2017) (0) |
| Sep 22, 2017 | 100 | MEMORANDUM in Support of APPLICATION to file document Memorandum in Support of Motion for Leave, First Amended Answer and Exhibits 1-15 under seal 92 , NOTICE OF MOTION AND MOTION for Leave to file First Amended Answer 91 (Redacted) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Redacted Document - Appendix A, # 2 Redacted Document - Appendix B)(Garvish, John) (Entered: 09/22/2017) (0) |
| Sep 21, 2017 | 96 | ORDER GRANTING DEFENDANTS APPLICATION TO FILE UNDER SEAL ITS MOTION FOR LEAVE TO FILE A FIRST AMENDED ANSWER 88 by Judge S. James Otero (lc) (Entered: 09/21/2017) (3) |
| Sep 21, 2017 | 97 | ORDER GRANTING IMMUNEXS AND AMGENS APPLICATION FOR LEAVE TOFILE DOCUMENTS UNDER SEAL 90 by Judge S. James Otero (lc) (Entered: 09/21/2017) (5) |
| Sep 21, 2017 | 98 | ORDER GRANTING DEFENDANTS APPLICATION TO FILE UNDER SEAL MEMORANDUM AND POINTS OF AUTHORITIES IN SUPPORT OF MOTION FOR LEAVE TO FILE A FIRST AMENDED ANSWER;FIRST AMENDED ANSWER; EXHIBITS THERETO; REDLINE OF FIRST AMENDED ANSWER 92 by Judge S. James Otero (lc) (Entered: 09/21/2017) (2) |
| Sep 18, 2017 | 90 | APPLICATION to file document Defendants' Motion for Leave to File A First Amended Answer under seal filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation. (Attachments: # 1 Declaration iso Application for Leave to File Documents Under Seal, # 2 Proposed Order Granting Application for Leave to File Documents Under Seal)(Takahashi, Heather Emily) (Entered: 09/18/2017) (0) |
| Sep 18, 2017 | 91 | NOTICE OF MOTION AND MOTION for Leave to file First Amended Answer filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 10/16/2017 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of John F. Garvish, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Proposed Order) (Garvish, John) (Entered: 09/18/2017) (0) |
| Sep 18, 2017 | 92 | APPLICATION to file document Memorandum in Support of Motion for Leave, First Amended Answer and Exhibits 1-15 under seal filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Declaration of John F. Garvish)(Garvish, John) (Entered: 09/18/2017) (0) |
| Sep 18, 2017 | 93 | SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Memorandum in Support of Motion for Leave, First Amended Answer and Exhibits 1-15 under seal 92 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Unredacted Document Memorandum in Support of Motion for Leave, # 2 Unredacted Document Appendix A - First Amended Answer, # 3 Unredacted Document Exhibit 1, # 4 Unredacted Document Exhibit 2, # 5 Unredacted Document Exhibit 3, # 6 Unredacted Document Exhibit 4, # 7 Unredacted Document Exhibit 5, # 8 Unredacted Document Exhibit 6, # 9 Unredacted Document Exhibit 7, # 10 Unredacted Document Exhibit 8, # 11 Unredacted Document Exhibit 9, # 12 Unredacted Document Exhibit 10, # 13 Unredacted Document Exhibit 11, # 14 Unredacted Document Exhibit 12, # 15 Unredacted Document Exhibit 13, # 16 Unredacted Document Exhibit 14, # 17 Unredacted Document Exhibit 15, # 18 Unredacted Document Appendix A - Redline of First Amended Answer)(Garvish, John) (Entered: 09/18/2017) (0) |
| Sep 18, 2017 | 94 | NOTICE OF MOTION AND MOTION to Strike Infringement Contentions and Compel More Definite Disclosure filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 10/16/2017 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum, # 2 Proposed Order, # 3 Declaration of John Garvish, # 4 Exhibit 1, # 5 Exhibit 2) (Garvish, John) (Entered: 09/18/2017) (0) |
| Sep 18, 2017 | 95 | NOTICE OF ERRATA filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. correcting NOTICE OF MOTION AND MOTION to Strike Infringement Contentions and Compel More Definite Disclosure 94 (Attachments: # 1 Exhibit 3 to the Declaration of John F. Garvish, II)(Garvish, John) (Entered: 09/18/2017) (0) |
| Sep 14, 2017 | 88 | APPLICATION for Leave to file Defendants' Application for Leave to File Under Seal Memorandum Of Points and Authorities In Support of Motion for Leave to File A First Amended Answer; First Amended Answer; Exhibits Thereto; Redline of First Amended Answer filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Declaration of John Garvish) (Dorman, Roderick) (Entered: 09/14/2017) (0) |
| Sep 14, 2017 | 89 | ORDER EXTENDING DEADLINE TO AMEND PLEADINGS 85 by Judge S. James Otero. IT IS HEREBY ORDERED, pursuant to the Stipulation of Parties, that the Deadline to Amend Pleadings in the above-captioned action shall be, and hereby is, extended to Monday, September 18, 2017. (lom) (Entered: 09/14/2017) (2) |
| Sep 11, 2017 | 87 | Joint STIPULATION for Extension of Time to Amend Scheduling Conference,,,, Vacate ADR Referral Notice,,,, Set/Reset Deadlines/Hearings,,, 80 filed by Defendant Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order)(Dorman, Roderick) (Entered: 09/11/2017) (0) |
| Sep 8, 2017 | 86 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Stipulation for Extension of Time to File 85 . The following error(s) was/were found: Proposed Document was not submitted as separate attachment. Other error(s) with document(s): [Prop] Order is efiled as a separate document and attached as a second attachment to Stipulation. To efile the [Prop] Order as a separate document, please do a Notice Lodging document as the main document and attach the [Prop] Order as the second attachment. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lom) (Entered: 09/08/2017) (2) |
| Sep 7, 2017 | 83 | Joint REQUEST for Protective Order for Discovery Requests STIPULATED PROTECTIVE ORDER filed by Plaintiff and Counterclaim-Defendants Immunex Corporation. (Takahashi, Heather Emily) (Entered: 09/07/2017) (26) |
| Sep 7, 2017 | 84 | MEMORANDUM AND ORDER RE: PARTIES' PROPOSED STIPULATED PROTECTIVE ORDER 83 by Magistrate Judge Paul L. Abrams. SEE ORDER FOR DETAILS. (ch) (Entered: 09/07/2017) (3) |
| Sep 7, 2017 | 85 | Joint STIPULATION for Extension of Time to File Amended Pleadings filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC.(Dorman, Roderick) (Entered: 09/07/2017) (4) |
| Aug 14, 2017 | 81 | TRANSCRIPT for proceedings held on 8/3/17 9:23 a.m. Court Reporter: Carol Jean Zurborg, phone number (213) 894-3539. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 9/5/2017. Redacted Transcript Deadline set for 9/14/2017. Release of Transcript Restriction set for 11/13/2017. (Zurborg, Carol) (Entered: 08/14/2017) (72) |
| Aug 14, 2017 | 82 | NOTICE OF FILING TRANSCRIPT filed for proceedings 8/3/17 9:23 a.m. re Transcript 81 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Zurborg, Carol) TEXT ONLY ENTRY (Entered: 08/14/2017) (0) |
| Aug 3, 2017 | 80 | MINUTES OF Scheduling Conference held before Judge S. James Otero.The Court sets the following schedule: last date to amend: 9/14/17; discovery cutoff: 8/17/18 ; motion hearing cutoff: 1/28/19 10:00 AM; pretrial conference: 3/4/19 9:00 AM; Jury trial: 3/19/19 9:00 AM; Markman Hearing: 3/12/18 10;00 AM. (SEE DOCUMENT FOR OTHER SPECIFIC DEADLINES). Reference of the above case to the Alternative Dispute Resolution Program is vacated. Settlement is referred to Private Mediation for all further proceedings All discovery dispute to be brought before the Magistrate Judge assigned to the case; parties reminded of requirements of FRCP 26-1(a); counsel are advised all pretrial documents (as listed) must be filed in compliance with Courts Initial Standing order. Court Reporter: Carol Zurborg. (lc) (Entered: 08/07/2017) (4) |
| Aug 2, 2017 | 79 | REFUND OF $400.00 made payable on 08/02/2017 to Phillip J Lee for payment made on 06/28/2017 Re: APPLICATION for Refund of Fees Paid Re: Application/Motion/Request (Attorney Civil Case Opening) 65 68 . (rdj) (Entered: 08/02/2017) (1) |
| Jul 28, 2017 | 78 | ANSWER to Answer to Complaint (Attorney Civil Case Opening),, Counterclaim, 64 with JURY DEMAND filed by Plaintiff and Counterclaim-Defendants Amgen Inc., Immunex Corporation.(Attorney Heather Emily Fitzgerald Takahashi added to party Amgen Inc.(pty:cd))(Takahashi, Heather Emily) (Entered: 07/28/2017) (26) |
| Jul 21, 2017 | 77 | STIPULATION Extending Time to Answer the complaint as to Immunex Corporation answer now due 7/28/2017, re Answer to Complaint (Attorney Civil Case Opening),, Counterclaim, 64 filed by Plaintiff and Counterclaim-Defendants Immunex Corporation.(Takahashi, Heather Emily) (Entered: 07/21/2017) (4) |
| Jul 17, 2017 | 76 | JOINT REPORT Rule 26(f) Discovery Plan ; estimated length of trial 8 days, filed by Counter Defendants Amgen Inc., Immunex Corporation, Plaintiff Immunex Corporation.. (Takahashi, Heather Emily) (Entered: 07/17/2017) (30) |
| Jul 12, 2017 | 75 | ORDER GRANTING APPLICATION of Non-Resident Attorney Larry A. Coury to Appear Pro Hac Vice on behalf of Counter Claimants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi and designating RoderickDorman as local counsel 74 by Judge S. James Otero (lc) (Entered: 07/12/2017) (1) |
| Jul 10, 2017 | 73 | ORDER GRANTING APPLICATION of Non-Resident Attorney Richard Brian McCaslin to Appear Pro Hac Vice on behalf of Defendants and counterclaimants Aventisub LLC, Genzyme Corporation and designating Roderick Dorman as local counsel 72 by Judge S. James Otero (lc) (Entered: 07/10/2017) (1) |
| Jul 10, 2017 | 74 | APPLICATION of Non-Resident Attorney Larry A. Coury to Appear Pro Hac Vice on behalf of Counter Claimants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20154696) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi. (Attachments: # 1 Exhibit A - Proposed Order, # 2 Exhibit B - Cert of Good Standing) (Dorman, Roderick) (Entered: 07/10/2017) (0) |
| Jul 6, 2017 | 72 | APPLICATION of Non-Resident Attorney Richard Brian McCaslin to Appear Pro Hac Vice on behalf of Counter Claimants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Defendants Aventisub LLC, Genzyme Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20136922) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - Proposed Order, # 2 Exhibit B - Certs of Good Standing) (Dorman, Roderick) (Entered: 07/06/2017) (0) |
| Jun 30, 2017 | 71 | 21 DAY Summons Issued re Counterclaim, 64 as to Counter defendants Amgen Inc. (lc) (Entered: 06/30/2017) (2) |
| Jun 29, 2017 | 67 | Request for Clerk to Issue Summons on Answer to Complaint (Attorney Civil Case Opening),, Counterclaim, 64 filed by Defendant Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC. (Garvish, John) (Entered: 06/29/2017) (2) |
| Jun 29, 2017 | 68 | APPLICATION for Refund of Fees Paid Re: Application/Motion/Request (Attorney Civil Case Opening) 65 filed by Defendant Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC. (Lee, Phillip) (Entered: 06/29/2017) (1) |
| Jun 29, 2017 | 69 | NOTICE OF DEFICIENCIES in Request to Issue Summons RE: Summons Request 65 . The following error(s) was found: 1) Incorrect event: Application/Motion/Request (Attorney Civil Case Opening). Correct event is: SUMMONS REQUEST; 2) near the Summons Tile, indicate "ON THE COUNTERCLAIM". The summons cannot be issued until this defect has been corrected. Please correct the defect and re-file your request. (lc) Modified on 6/29/2017 (lc). (Entered: 06/29/2017) (1) |
| Jun 29, 2017 | 70 | Request for Clerk to Issue Summons on Answer to Complaint (Attorney Civil Case Opening),, Counterclaim, 64 filed by Counter-Claimants Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC. (Lee, Phillip) (Entered: 06/29/2017) (2) |
| Jun 28, 2017 | 64 | ANSWER to Complaint (Attorney Civil Case Opening), 1 with JURY DEMANDDefendants' Answer to Immunex's Complaint for Patent Infringement and Counterclaim-Plaintiffs' Counterclaims Against Immunex and Amgen, COUNTERCLAIM against Immunex Corporation, Amgen Inc. filed by Defendants Sanofi, Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC, Regeneron Pharmaceuticals, Inc..(Garvish, John) (Entered: 06/28/2017) (30) |
| Jun 28, 2017 | 65 | REQUEST for Clerk to Issue Summons on Counterclaims Receipt No: 0973-20100210 - Fee: $400, filed by Defendants Genzyme Corporation, Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Regeneron Pharmaceuticals, Inc..(Garvish, John) (Entered: 06/28/2017) (2) |
| Jun 28, 2017 | 66 | ORDER GRANTING APPLICATION of Non-Resident Attorney Sarah G. Boyce to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation and designating Gregory P Stone as local counsel 63 by Judge S. James Otero (lc) (Entered: 06/28/2017) (1) |
| Jun 26, 2017 | 63 | APPLICATION of Non-Resident Attorney Sarah G. Boyce to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20081960) filed by Immunex Corporation Immunex Corporation. (Attachments: # 1 Proposed Order, # 2 Certificate of Good Standing (DC), # 3 Certificate of Good Standing (Maryland)) (Stone, Gregory) (Entered: 06/26/2017) (0) |
| Jun 21, 2017 | 62 | MINUTES (IN CHAMBERS) - ORDER DENYING DEFENDANTS' MOTION TO DISMISS PLAINTIFF'S COMPLAINT UNDER FED. R. CIV. P. 12(b)(6) 33 by Judge S. James Otero. The Court DENIES Defendants Sanofi, Sanofi-Aventis U.S. LLC, Genzyme Corporation and Aventisub LLC and Regeneron Pharmaceuticals, Inc.'s Motion to Dismiss Plaintiff's Complaint Under Fed. R. Civ. P. 12(b)(6) 33 . Defendants shall file their answers the Complaint within seven (7) days of the issuance of this Order. The Court SETS a scheduling conference for Thursday, August 3, 2017 at 9:00 am and ORDERS the parties to file their Joint Rule 26(f) Report on or before Monday, July 17, 2017. During the scheduling conference, the Court wishes to have the parties provide a technology tutorial and overview of likely contested and potentially dispositive issues. The parties will have 30 minutes each to present their tutorials, and welcomes the use of PowerPoint presentations and slides that it and its staff can use as aids. See document for details. (smo) (Entered: 06/21/2017) (8) |
| Jun 20, 2017 | 61 | TEXT ONLY ENTRY by Judge S. James Otero. On the Court's own motion, the Court takes off calendar and under submission, the MOTION to Dismiss Case and filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, and Sanofi-Aventis U.S. LLC 33 , previously scheduled for 6/26/2017 at 10:00 a.m. No appearance is necessary. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 06/20/2017) (0) |
| Jun 16, 2017 | 60 | ORDER GRANTING APPLICATION of Non-Resident Attorney Lynda Quang Nguyen to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC and designating Roderick Dorman as local counsel 59 by Judge S. James Otero (lc) (Entered: 06/16/2017) (1) |
| Jun 15, 2017 | 59 | APPLICATION of Non-Resident Attorney Lynda Quang Nguyen to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt N o. 0973-20028128) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Certificate of Good Standing) (Dorman, Roderick) (Entered: 06/15/2017) (0) |
| Jun 12, 2017 | 57 | ORDER GRANTING APPLICATION of Non-Resident Attorney K. Nicole Clouse to appear for Plaintiff Immunex Corporation and designating Gregory P Stone as local counsel 56 by Judge S. James Otero (lc) (Entered: 06/12/2017) (1) |
| Jun 12, 2017 | 58 | RESPONSE IN SUPPORT of NOTICE OF MOTION AND MOTION to Dismiss Case and Memorandum of Points and Authorities in Support Thereof 33 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Declaration of Phillip J. Lee, # 2 Exhibit A to Lee Declaration)(Dorman, Roderick) (Entered: 06/12/2017) (0) |
| Jun 8, 2017 | 56 | Corrected APPLICATION to APPLICATION of Non-Resident Attorney K. Nicole Clouse to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19963042) 43 filed by Immunex Corporation Immunex Corporation. (Attachments: # 1 Proposed Order, # 2 Certificate of Good Standing) (Stone, Gregory) (Entered: 06/08/2017) (0) |
| Jun 7, 2017 | 47 | RESPONSE BY THE COURT TO NOTICE TO FILER OF DEFICIENCIES IN ELECTRONICALLY FILED DOCUMENTS RE: APPLICATION of Non-Resident Attorney Sarah Chapin Columbia to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19963255) 44 by Judge S. James Otero. The document is stricken and counsel is ordered to file an amended or corrected document by 6/9/2017. (smo) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 48 | ORDER GRANTING APPLICATION of Non-Resident Attorney John F. Garvish to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis and designating Roderick G Dorman as local counsel 36 by Judge S. James Otero: (lc) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 49 | ORDER GRANTING APPLICATION of Non-Resident Attorney Matthew Cameron to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis and designating Roderick G Dorman as local counsel 37 by Judge S. James Otero (lc) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 50 | ORDER GRANTING APPLICATION of Non-Resident Attorney Geoffrey L Smith to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis and designating Roderick Dorman as local counsel 38 by Judge S. James Otero (lc) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 51 | ORDER GRANTING APPLICATION of Non-Resident Attorney Mike McKool o Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis and designating Roderick G Dorman as local counsel 39 by Judge S. James Otero (lc) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 52 | ORDER GRANTING APPLICATION of Non-Resident Attorney Lauren L. Fornarotto to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis and designating Roderick G Dorman as local counsel 40 by Judge S. James Otero: (lc) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 53 | ORDER GRANTING APPLICATION of Non-Resident Attorney Radu A.Lelutiu to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis and designating Roderick G Dorman as local counsel 41 by Judge S. James Otero (lc) (Entered: 06/07/2017) (1) |
| Jun 7, 2017 | 54 | INITIAL STANDING ORDER upon filing of the complaint by Judge S. James Otero. (vcr) (Entered: 06/07/2017) (30) |
| Jun 7, 2017 | 55 | CORRECTED RESPONSE BY THE COURT TO NOTICE TO FILER OF DEFICIENCIES IN ELECTRONICALLY FILED DOCUMENTS RE: APPLICATION of Non-Resident Attorney K. Nicole Clouse to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19963042) 43 by Clerk of Court. The document is stricken and counsel is ordered to file an amended or corrected document by 6/9/17. (lc) (Entered: 06/07/2017) (1) |
| Jun 6, 2017 | 46 | NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney K. Nicole Clouse to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19963042) 43 . The following error(s) was/were found: Local Rule 83-2.1.3.3(a) Application not complete: state and/or federal courts to which the applicant has been admitted are not listed. (lt) (Entered: 06/06/2017) (1) |
| Jun 5, 2017 | 42 | Notice of Appearance or Withdrawal of Counsel: for attorney Heather Emily Fitzgerald Takahashi counsel for Plaintiff Immunex Corporation. Adding Nathan A. Machin as counsel of record for Immunex Corporation for the reason indicated in the G-123 Notice. Filed by Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 06/05/2017) (2) |
| Jun 5, 2017 | 43 | APPLICATION of Non-Resident Attorney K. Nicole Clouse to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19963042) filed by Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order, # 2 Certificate of Good Standing) (Takahashi, Heather Emily) Modified on 6/7/2017 (lc).(STRICKEN PER CORRECTED COURTS RESPONSE G112B) (Entered: 06/05/2017) (0) |
| Jun 5, 2017 | 44 | STRICKEN - APPLICATION of Non-Resident Attorney Sarah Chapin Columbia to Appear Pro Hac Vice on behalf of Plaintiff Immunex Corporation (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19963255) filed by Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order, # 2 Certificate of Good Standing) (Takahashi, Heather Emily) Modified on 6/7/2017 (smo). (Entered: 06/05/2017) (0) |
| Jun 5, 2017 | 45 | MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Dismiss Case and Memorandum of Points and Authorities in Support Thereof 33 filed by Plaintiff Immunex Corporation. (Attachments: # 1 Declaration Takahashi Decl iso Immunex's Opposition to Motion to Dismiss)(Takahashi, Heather Emily) (Entered: 06/05/2017) (0) |
| May 30, 2017 | 35 | NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: ONLY THE ATTACHED PROPOSED ORDERS TO NOTICE OF MOTION AND MOTION to Dismiss Case [33-1], AND Request for Judicial Notice, [34-1]. The following error(s) was found: Other error(s) with document(s) are specified below: L.R. 58-10 at least 2 lines of text must accompany the Signature Line for Signature of Judge on a last page of proposed order (33-1 it is so order stands alone on last page; 34-1, less than one line on last page). In response to this notice the court may order (1) an amended or correct document to be filed (2) the document stricken or (3) take other action as the court deems appropriate. You need not take any action in response to this notice unless and until the court directs you to do so. (lc) (Entered: 05/30/2017) (1) |
| May 30, 2017 | 36 | APPLICATION of Non-Resident Attorney John F. Garvish to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19934546) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate(s) of Good Standing, # 2 Proposed Order) (Dorman, Roderick) (Entered: 05/30/2017) (0) |
| May 30, 2017 | 37 | APPLICATION of Non-Resident Attorney Matthew Cameron to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19934972) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate(s) of Good Standing, # 2 Proposed Order) (Dorman, Roderick) (Entered: 05/30/2017) (0) |
| May 30, 2017 | 38 | APPLICATION of Non-Resident Attorney Geoffrey L. Smith to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt No . 0973-19935349) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate(s) of Good Standing, # 2 Proposed Order) (Dorman, Roderick) (Entered: 05/30/2017) (0) |
| May 30, 2017 | 39 | APPLICATION of Non-Resident Attorney Mike McKool to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973 -19935449) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate(s) of Good Standing, # 2 Proposed Order) (Dorman, Roderick) (Entered: 05/30/2017) (0) |
| May 30, 2017 | 40 | APPLICATION of Non-Resident Attorney Lauren L. Fornarotto to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19935566) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate(s) of Good Standing, # 2 Proposed Order) (Dorman, Roderick) (Entered: 05/30/2017) (0) |
| May 30, 2017 | 41 | APPLICATION of Non-Resident Attorney Radu A. Lelutiu to Appear Pro Hac Vice on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-19935644) filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate(s) of Good Standing, # 2 Proposed Order) (Dorman, Roderick) (Entered: 05/30/2017) (0) |
| May 26, 2017 | 32 | NOTICE of Appearance filed by attorney Christine Michelle Woodin on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Attorney Christine Michelle Woodin added to party Aventisub LLC(pty:dft), Attorney Christine Michelle Woodin added to party Genzyme Corporation(pty:dft), Attorney Christine Michelle Woodin added to party Regeneron Pharmaceuticals, Inc.(pty:dft), Attorney Christine Michelle Woodin added to party Sanofi(pty:dft), Attorney Christine Michelle Woodin added to party Sanofi-Aventis U.S. LLC(pty:dft))(Woodin, Christine) (Entered: 05/26/2017) (2) |
| May 26, 2017 | 33 | NOTICE OF MOTION AND MOTION to Dismiss Case and Memorandum of Points and Authorities in Support Thereof filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. Motion set for hearing on 6/26/2017 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order) (Dorman, Roderick) (Entered: 05/26/2017) (0) |
| May 26, 2017 | 34 | REQUEST FOR JUDICIAL NOTICE re NOTICE OF MOTION AND MOTION to Dismiss Case and Memorandum of Points and Authorities in Support Thereof 33 filed by Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Proposed Order, # 2 Declaration of Phillip Lee, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Dorman, Roderick) (Entered: 05/26/2017) (0) |
| May 25, 2017 | 29 | NOTICE of Appearance filed by attorney Roderick G Dorman on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Attorney Roderick G Dorman added to party Aventisub LLC(pty:dft), Attorney Roderick G Dorman added to party Genzyme Corporation(pty:dft), Attorney Roderick G Dorman added to party Regeneron Pharmaceuticals, Inc.(pty:dft), Attorney Roderick G Dorman added to party Sanofi(pty:dft), Attorney Roderick G Dorman added to party Sanofi-Aventis U.S. LLC. (Dorman, Roderick) (Entered: 05/25/2017) (2) |
| May 25, 2017 | 30 | NOTICE of Interested Parties filed by Defendants All Defendants, (Dorman, Roderick) (Entered: 05/25/2017) (4) |
| May 25, 2017 | 31 | NOTICE of Appearance filed by attorney Phillip Jeung Lee on behalf of Defendants Aventisub LLC, Genzyme Corporation, Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis U.S. LLC (Attorney Phillip Jeung Lee added to party Aventisub LLC(pty:dft), Attorney Phillip Jeung Lee added to party Genzyme Corporation(pty:dft), Attorney Phillip Jeung Lee added to party Regeneron Pharmaceuticals, Inc.(pty:dft), Attorney Phillip Jeung Lee added to party Sanofi(pty:dft), Attorney Phillip Jeung Lee added to party Sanofi-Aventis U.S. LLC(pty:dft))(Lee, Phillip) (Entered: 05/25/2017) (2) |
| Apr 19, 2017 | 28 | ORDER REGARDING STIPULATION TO EXTEND TIME TO RESPOND TO INITIAL COMPLAINT BY NOT MORE THAN 30 DAYS (L.R. 8-3) granting Stipulation for Extension of Time to File Response/Reply 25 by Judge S. James Otero. IT IS HEREBY ORDERED THAT the time for Defendants to answer or otherwise respond to Plaintiff's Complaint, currently May 5, 2017, shall be extended to May 26, 2017. (smo) (Entered: 04/19/2017) (1) |
| Apr 17, 2017 | 25 | STIPULATION for Extension of Time to File Response as to Complaint (Attorney Civil Case Opening), 1 filed by Plaintiff Immunex Corporation. (Attachments: # 1 Proposed Order)(Takahashi, Heather Emily) (Entered: 04/17/2017) (0) |
| Apr 17, 2017 | 26 | NOTICE OF ERRATA filed by Plaintiff Immunex Corporation. correcting Stipulation for Extension of Time to File Response/Reply 25 Re [Proposed] Order (Takahashi, Heather Emily) (Entered: 04/17/2017) (1) |
| Apr 17, 2017 | 27 | NOTICE OF LODGING filed [Proposed] Order re Stipulation for Extension of Time to File Response/Reply 25 , Errata 26 (Attachments: # 1 Exhibit [Proposed] Order Regarding Stipulation to Extend Time to Respond to Initial Complaint by Not More than 30 Days)(Takahashi, Heather Emily) (Entered: 04/17/2017) (0) |
| Apr 14, 2017 | 20 | PROOF OF SERVICE Executed by Plaintiff Immunex Corporation, upon Defendant Sanofi served on 4/14/2017, answer due 5/5/2017. Service of the Summons and Complaint were executed upon John Garvish, Counsel for Sanofi in compliance with Federal Rules of Civil Procedure by method of service not specified.Original Summons returned. (Takahashi, Heather Emily) (Entered: 04/14/2017) (2) |
| Apr 14, 2017 | 21 | PROOF OF SERVICE Executed by Plaintiff Immunex Corporation, upon Defendant Sanofi-Aventis U.S. LLC served on 4/14/2017, answer due 5/5/2017. Service of the Summons and Complaint were executed upon John Garvish, Counsel for Sanofi-Aventis U.S. LLC in compliance with Federal Rules of Civil Procedure by service on a domestic corporation, unincorporated association, or public entity.Original Summons returned. (Takahashi, Heather Emily) (Entered: 04/14/2017) (2) |
| Apr 14, 2017 | 22 | PROOF OF SERVICE Executed by Plaintiff Immunex Corporation, upon Defendant Genzyme Corporation served on 4/14/2017, answer due 5/5/2017. Service of the Summons and Complaint were executed upon John Garvish, Counsel Genzyme Corporation in compliance with Federal Rules of Civil Procedure by service on a domestic corporation, unincorporated association, or public entity.Original Summons returned. (Takahashi, Heather Emily) (Entered: 04/14/2017) (2) |
| Apr 14, 2017 | 23 | PROOF OF SERVICE Executed by Plaintiff Immunex Corporation, upon Defendant Aventisub LLC served on 4/14/2017, answer due 5/5/2017. Service of the Summons and Complaint were executed upon John Garvish, Counsel for Aventisub LLC in compliance with Federal Rules of Civil Procedure by service on a domestic corporation, unincorporated association, or public entity.Original Summons returned. (Takahashi, Heather Emily) (Entered: 04/14/2017) (2) |
| Apr 14, 2017 | 24 | PROOF OF SERVICE Executed by Plaintiff Immunex Corporation, upon Defendant Regeneron Pharmaceuticals, Inc. served on 4/14/2017, answer due 5/5/2017. Service of the Summons and Complaint were executed upon John Garvish, Counsel for Regeneron Pharmaceuticals, Inc. in compliance with Federal Rules of Civil Procedure by service on a domestic corporation, unincorporated association, or public entity.Original Summons returned. (Takahashi, Heather Emily) (Entered: 04/14/2017) (2) |
| Apr 13, 2017 | 16 | NOTICE OF DEFICIENCIES in Request to Issue Summons RE: Summons Request 13 . The following error(s) was found: The case number and/or judge(s)initials are incorrect. The caption of the summons must match the caption of the complaint verbatim. If the caption is too large to fit in the space provided, enter the name of the first party and then write see attached.Next, attach a face page of the complaint or a second page addendum to the Summons. Summons is not directed to the defendant(s). The defendants name must appear in the To:section of the summons. 1) Case number incomplete. Per 4/7/17 reassignment order, case number to read correctly as: 2:17-cv-2613 SJO-PLA. 2) Name of the defendant Aventisub LLC Missing on caption 3) Name of same defendant does not match verbatim in the TO: area. Filer has added additional alias which do not appear in the complaint. There is no Named defendant as named with the aliases as: "Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc.". The summons cannot be issued until this defect has been corrected. Please correct the defect and re-file your request. (lc) (Entered: 04/13/2017) (2) |
| Apr 13, 2017 | 17 | CORRECTED NOTICE OF DEFICIENCIES in Request to Issue Summons RE: Notice of Deficiency in Request to Issue Summons,,,, 16 . The following error(s) was found: The case number and/or judge(s)initials are incorrect. Summons is not directed to the defendant(s). The defendants name must appear in the To:section of the summons. CORRECTED : 1) Case number incomplete. Per 4/7/17 reassignment order, case number to read correctly as: 2:17-cv-2613 SJO-PLA. 2) Name of the defendant Aventisub LLC does not t match verbatim in the TO: area. Filer has added additional alias which do not appear in the complaint. There is no Named defendant as named with the aliases as: "Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc.".. The summons cannot be issued until this defect has been corrected. Please correct the defect and re-file your request. (lc) (Entered: 04/13/2017) (2) |
| Apr 13, 2017 | 18 | Request for Clerk to Issue Summons on Complaint (Attorney Civil Case Opening), 1 filed by Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 04/13/2017) (2) |
| Apr 13, 2017 | 19 | 21 DAY Summons Issued re Complaint (Attorney Civil Case Opening), 1 as to defendant Aventisub LLC. (lc) (Entered: 04/13/2017) (2) |
| Apr 7, 2017 | 14 | ORDER TO TRANSFER CASE TO THE PATENT PILOT PROGRAM by Judge Dolly M. Gee. Case transferred from Judge Dolly M. Gee to Judge S. James Otero for all further proceedings. Case number now reads 2:17-cv-02613 SJO (PLAx). (esa) (Entered: 04/07/2017) (1) |
| Apr 7, 2017 | 15 | INITIAL STANDING ORDER upon filing of the complaint by Judge S. James Otero. (vcr) (Entered: 04/07/2017) (30) |
| Apr 6, 2017 | 6 | NOTICE OF ASSIGNMENT to District Judge Dolly M. Gee and Magistrate Judge Paul L. Abrams. (ghap) (Entered: 04/06/2017) (1) |
| Apr 6, 2017 | 7 | NOTICE TO PARTIES OF COURT-DIRECTED ADR PROGRAM filed. (ghap) (Entered: 04/06/2017) (2) |
| Apr 6, 2017 | 8 | 21 DAY Summons Issued re Complaint (Attorney Civil Case Opening), 1 as to Defendant Sanofi. (ghap) (Entered: 04/06/2017) (2) |
| Apr 6, 2017 | 9 | 21 DAY Summons Issued re Complaint (Attorney Civil Case Opening), 1 as to Defendant Sanofi-Aventis U.S. LLC. (ghap) (Entered: 04/06/2017) (2) |
| Apr 6, 2017 | 10 | 21 DAY Summons Issued re Complaint (Attorney Civil Case Opening), 1 as to Defendant Genzyme Corporation. (ghap) (Entered: 04/06/2017) (2) |
| Apr 6, 2017 | 11 | 21 DAY Summons Issued re Complaint (Attorney Civil Case Opening), 1 as to Defendant Regeneron Pharmaceuticals, Inc. (ghap) (Entered: 04/06/2017) (2) |
| Apr 6, 2017 | 12 | NOTICE OF DEFICIENCIES in Request to Issue Summons RE: Summons Request 3 . The following error(s) was found: The caption of the summons must match the caption of the complaint verbatim. If the caption is too large to fit in the space provided, enter the name of the first party and then write see attached.Next, attach a face page of the complaint or a second page addendum to the Summons. The summons cannot be issued until this defect has been corrected. Please correct the defect and re-file your request. (ghap) (Entered: 04/06/2017) (2) |
| Apr 6, 2017 | 13 | Request for Clerk to Issue Summons on Complaint (Attorney Civil Case Opening), 1 filed by Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 04/06/2017) (2) |
| Apr 5, 2017 | 2 | CIVIL COVER SHEET filed by Plaintiff Immunex Corporation. (Takahashi, Heather Emily) (Entered: 04/05/2017) (3) |
| Apr 5, 2017 | 3 | Request for Clerk to Issue Summons on Complaint (Attorney Civil Case Opening), 1 filed by Plaintiff Immunex Corporation. (Attachments: # 1 Summons)(Takahashi, Heather Emily) (Entered: 04/05/2017) (0) |
| Apr 5, 2017 | 4 | Certification and NOTICE of Interested Parties filed by Plaintiff Immunex Corporation, identifying Amgen Inc.. (Takahashi, Heather Emily) (Entered: 04/05/2017) (1) |
| Apr 5, 2017 | 5 | REPORT ON THE FILING OF AN ACTION Regarding a Patent or a Trademark (Initial Notification) filed by Immunex Corporation. (Takahashi, Heather Emily) (Entered: 04/05/2017) (1) |
| Apr 5, 2017 | 1 | Complaint* (1) |
